| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | SMG1 MARK1 OBSCN BCR MAP3K1 RPS6KC1 MYO3A CDC42BPA LRRK1 ACVR1C TGFBR2 MAPK14 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 4.09e-06 | 446 | 206 | 17 | GO:0004674 |
| GeneOntologyMolecularFunction | protein serine kinase activity | SMG1 MARK1 OBSCN BCR MAP3K1 RPS6KC1 MYO3A CDC42BPA LRRK1 MAPK14 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 5.88e-06 | 363 | 206 | 15 | GO:0106310 |
| GeneOntologyMolecularFunction | microtubule motor activity | 7.77e-06 | 70 | 206 | 7 | GO:0003777 | |
| GeneOntologyMolecularFunction | MAP kinase activity | 1.82e-05 | 16 | 206 | 4 | GO:0004707 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.01e-05 | 18 | 206 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.10e-05 | 118 | 206 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 3.71e-05 | 37 | 206 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | SMG1 UAP1 MARK1 OBSCN RBKS PFKP BCR MAP3K1 RPS6KC1 MYO3A SGMS1 PI4KA GMPPB CDC42BPA POLD1 LRRK1 ACVR1C TGFBR2 MAPK14 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 3.94e-05 | 938 | 206 | 24 | GO:0016772 |
| GeneOntologyMolecularFunction | kinase activity | SMG1 MARK1 OBSCN RBKS PFKP BCR MAP3K1 RPS6KC1 MYO3A SGMS1 PI4KA CDC42BPA LRRK1 ACVR1C TGFBR2 MAPK14 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 4.47e-05 | 764 | 206 | 21 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | SMG1 MARK1 OBSCN RBKS PFKP BCR MAP3K1 RPS6KC1 MYO3A PI4KA CDC42BPA LRRK1 ACVR1C TGFBR2 MAPK14 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 4.79e-05 | 709 | 206 | 20 | GO:0016773 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | OBSCN BCR DENND5A ARHGEF37 DENND5B ARFGEF1 PLCD4 ARFGEF3 RASGRP1 EGF | 1.49e-04 | 231 | 206 | 10 | GO:0005085 |
| GeneOntologyMolecularFunction | protein kinase activity | SMG1 MARK1 OBSCN BCR MAP3K1 RPS6KC1 MYO3A CDC42BPA LRRK1 ACVR1C TGFBR2 MAPK14 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 1.71e-04 | 600 | 206 | 17 | GO:0004672 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.86e-04 | 28 | 206 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC4 ERCC6 KIF26A ABCA13 ACSL3 ACSL4 MYO3A STARD9 DNAH5 DNAH8 PIF1 RBBP4 DNAH12 DNAH17 MACF1 KIF4B SNRNP200 | 2.24e-04 | 614 | 206 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.78e-04 | 31 | 206 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | palmitoyl-CoA ligase activity | 3.16e-04 | 3 | 206 | 2 | GO:0090433 | |
| GeneOntologyMolecularFunction | actin filament binding | 6.04e-04 | 227 | 206 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | MAP kinase kinase activity | 7.88e-04 | 18 | 206 | 3 | GO:0004708 | |
| GeneOntologyMolecularFunction | C-X3-C chemokine binding | 1.04e-03 | 5 | 206 | 2 | GO:0019960 | |
| GeneOntologyMolecularFunction | protein-lysine 6-oxidase activity | 1.04e-03 | 5 | 206 | 2 | GO:0004720 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | OBSCN PFKP ITGB1 ITGB2 ITGB3 MMP24 PTPN11 PI4KA FERMT2 GCN1 NRCAM DSP ADAMTS13 P2RX4 MACF1 | 1.44e-03 | 599 | 206 | 15 | GO:0050839 |
| GeneOntologyBiologicalProcess | epithelial cell migration | CORO1C ITGB1 ITGB2 ITGB3 PTPN11 ADAMTS9 AGTR2 TGFBR2 CORO1A MAPK14 EGF P2RX4 EGR3 LOXL2 MACF1 MAP2K5 | 5.22e-06 | 432 | 200 | 16 | GO:0010631 |
| GeneOntologyBiologicalProcess | epithelium migration | CORO1C ITGB1 ITGB2 ITGB3 PTPN11 ADAMTS9 AGTR2 TGFBR2 CORO1A MAPK14 EGF P2RX4 EGR3 LOXL2 MACF1 MAP2K5 | 5.69e-06 | 435 | 200 | 16 | GO:0090132 |
| GeneOntologyBiologicalProcess | tissue migration | CORO1C ITGB1 ITGB2 ITGB3 PTPN11 ADAMTS9 AGTR2 TGFBR2 CORO1A MAPK14 EGF P2RX4 EGR3 LOXL2 MACF1 MAP2K5 | 6.76e-06 | 441 | 200 | 16 | GO:0090130 |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | CORO1C ITGB1 ITGB2 ITGB3 PTPN11 ADAMTS9 AGTR2 FOLR1 ACVR1C TGFBR2 CORO1A MAPK14 EGF P2RX4 EGR3 LOXL2 MACF1 MAP2K5 | 1.41e-05 | 577 | 200 | 18 | GO:0001667 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | SMG1 ERCC6 GALNT3 MARK1 TRPC5 ITGB1 ITGB2 ITGB3 TSPAN9 MYO3A PTPN11 LOXL4 POGLUT2 CDC42BPA LRRK1 IFNA6 LIPT1 MAPK14 EGF LOXL2 GALNT6 MAPK1 IKBKB MAPK13 | 2.73e-05 | 976 | 200 | 24 | GO:0018193 |
| GeneOntologyBiologicalProcess | heterotypic cell-cell adhesion | 4.32e-05 | 66 | 200 | 6 | GO:0034113 | |
| GeneOntologyBiologicalProcess | response to growth factor | DOK5 GALNT3 ITGB1 ITGB3 RYR1 MAP3K1 PTPN11 AGTR2 FERMT2 RBBP4 FOLR1 GDF15 ACVR1C PPM1A TGFBR2 CORO1A UBE2O MAPK14 EGR3 FIBP MAPK1 MAP2K5 | 4.98e-05 | 883 | 200 | 22 | GO:0070848 |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | CORO1C THSD1 BCR ITGB1 ITGB2 ITGB3 PTPN11 ADAMTS9 FERMT2 ADAMTS13 MACF1 | 6.92e-05 | 270 | 200 | 11 | GO:0007160 |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | DOK5 GALNT3 ITGB1 ITGB3 RYR1 MAP3K1 PTPN11 AGTR2 FERMT2 RBBP4 FOLR1 GDF15 ACVR1C PPM1A TGFBR2 CORO1A UBE2O MAPK14 EGR3 FIBP MAP2K5 | 8.39e-05 | 850 | 200 | 21 | GO:0071363 |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | EPOR XIRP1 ITGB1 ADAMTS9 AGTR2 DSP SYNE1 TGFBR2 MAPK14 MAPK1 MAPK11 G6PD | 8.83e-05 | 327 | 200 | 12 | GO:0048738 |
| GeneOntologyBiologicalProcess | cell-substrate junction assembly | 8.85e-05 | 108 | 200 | 7 | GO:0007044 | |
| GeneOntologyBiologicalProcess | angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure | 9.36e-05 | 2 | 200 | 2 | GO:0002033 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid localization | 1.11e-04 | 78 | 200 | 6 | GO:1905953 | |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 1.31e-04 | 115 | 200 | 7 | GO:0150115 | |
| GeneOntologyBiologicalProcess | lipid localization | ABCC4 ABCA13 TRPC5 STARD10 ITGB3 ACSL3 ACSL4 PTPN11 AGTR2 SLC25A11 DENND5B PNPLA2 ACVR1C EGF P2RX4 VPS13B | 1.33e-04 | 565 | 200 | 16 | GO:0010876 |
| GeneOntologyBiologicalProcess | striated muscle tissue development | EPOR XIRP1 ITGB1 ADAMTS9 AGTR2 DSP SYNE1 TGFBR2 MAPK14 MAPK1 MAPK11 G6PD | 1.62e-04 | 349 | 200 | 12 | GO:0014706 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | CORO1C THSD1 BCR ITGB1 ITGB2 ITGB3 PTPN11 ADAMTS9 FERMT2 ADAMTS13 CORO1A SORBS3 MACF1 | 1.93e-04 | 410 | 200 | 13 | GO:0031589 |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | CFH ERCC6 SPTA1 TRPM2 BCR ITGB1 ITGB3 TSPAN9 PTPN11 TRPM8 HTR4 GDF15 FLVCR1 LRRK1 ACVR1C EPG5 CORO1A MAPK14 P2RX4 IKBKB MAPK11 G6PD VPS13B | 2.06e-04 | 1043 | 200 | 23 | GO:0048871 |
| GeneOntologyBiologicalProcess | negative regulation of lipid transport | 2.08e-04 | 56 | 200 | 5 | GO:0032369 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 2.10e-04 | 124 | 200 | 7 | GO:0007229 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine modification | 2.20e-04 | 125 | 200 | 7 | GO:0018210 | |
| GeneOntologyBiologicalProcess | regulation of lipid localization | 2.60e-04 | 215 | 200 | 9 | GO:1905952 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic neurotransmitter receptor diffusion trapping | 2.79e-04 | 3 | 200 | 2 | GO:0150054 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | SMG1 ERCC6 GALNT3 MARK1 MYO3A POGLUT2 IFNA6 MAPK14 MAPK1 IKBKB MAPK13 | 2.97e-04 | 319 | 200 | 11 | GO:0018209 |
| GeneOntologyBiologicalProcess | glycerolipid metabolic process | SMG1 INPP4A INSIG1 ACSL3 ACSL4 PTPN11 LIPH PI4KA DAGLA PNPLA2 PLCD4 MTMR14 SLC44A3 | 2.99e-04 | 429 | 200 | 13 | GO:0046486 |
| GeneOntologyBiologicalProcess | glycerolipid biosynthetic process | SMG1 INPP4A ACSL3 ACSL4 LIPH PI4KA DAGLA PNPLA2 MTMR14 SLC44A3 | 3.00e-04 | 268 | 200 | 10 | GO:0045017 |
| GeneOntologyBiologicalProcess | receptor diffusion trapping | 3.02e-04 | 14 | 200 | 3 | GO:0098953 | |
| GeneOntologyBiologicalProcess | stress-activated MAPK cascade | 3.12e-04 | 61 | 200 | 5 | GO:0051403 | |
| GeneOntologyBiologicalProcess | focal adhesion assembly | 3.66e-04 | 97 | 200 | 6 | GO:0048041 | |
| GeneOntologyBiologicalProcess | regulation of lipid transport | 3.69e-04 | 179 | 200 | 8 | GO:0032368 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | ITGB1 RYR1 MAP3K1 FERMT2 RBBP4 FOLR1 GDF15 ACVR1C PPM1A TGFBR2 | 3.79e-04 | 276 | 200 | 10 | GO:0007179 |
| GeneOntologyBiologicalProcess | lipid export from cell | 3.91e-04 | 64 | 200 | 5 | GO:0140353 | |
| GeneOntologyBiologicalProcess | endothelial cell migration | ITGB1 ITGB2 ITGB3 ADAMTS9 AGTR2 MAPK14 EGF P2RX4 EGR3 LOXL2 MAP2K5 | 4.05e-04 | 331 | 200 | 11 | GO:0043542 |
| GeneOntologyBiologicalProcess | lipid transport | ABCC4 ABCA13 TRPC5 STARD10 ITGB3 ACSL3 ACSL4 PTPN11 AGTR2 SLC25A11 DENND5B EGF P2RX4 VPS13B | 4.41e-04 | 506 | 200 | 14 | GO:0006869 |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.18e-04 | 25 | 216 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | outer dynein arm | 2.23e-04 | 12 | 216 | 3 | GO:0036157 | |
| GeneOntologyCellularComponent | dynein complex | 2.36e-04 | 54 | 216 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | side of membrane | CFH EPOR ABCC4 SPTA1 GNG14 ITGB1 ITGB2 ITGB3 RYR1 BTN2A2 ANTXR2 CD163L1 BTN1A1 TRPM8 FERMT2 NRCAM DIABLO FOLR1 TGFBR2 IKBKB G6PD | 3.05e-04 | 875 | 216 | 21 | GO:0098552 |
| GeneOntologyCellularComponent | integrin alpha9-beta1 complex | 3.17e-04 | 3 | 216 | 2 | GO:0034679 | |
| GeneOntologyCellularComponent | focal adhesion | XIRP1 CORO1C THSD1 ITGB1 ITGB2 ITGB3 TSPAN9 PI4KA FERMT2 APBB1IP KLF11 SORBS3 MAPK1 | 5.75e-04 | 431 | 216 | 13 | GO:0005925 |
| Domain | DUF1220 | 4.38e-06 | 11 | 205 | 4 | PF06758 | |
| Domain | NBPF_dom | 4.38e-06 | 11 | 205 | 4 | IPR010630 | |
| Domain | NBPF | 4.38e-06 | 11 | 205 | 4 | PS51316 | |
| Domain | MAPK_p38 | 5.17e-06 | 4 | 205 | 3 | IPR008352 | |
| Domain | MAPK | 6.51e-06 | 12 | 205 | 4 | PS01351 | |
| Domain | MAP_kinase_CS | 6.51e-06 | 12 | 205 | 4 | IPR003527 | |
| Domain | Ser/Thr_kinase_AS | MARK1 OBSCN MAP3K1 RPS6KC1 MYO3A CDC42BPA LRRK1 ACVR1C TGFBR2 MAPK14 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 9.98e-06 | 357 | 205 | 15 | IPR008271 |
| Domain | S_TKc | MARK1 OBSCN MAP3K1 RPS6KC1 MYO3A CDC42BPA LRRK1 ACVR1C TGFBR2 MAPK14 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 1.07e-05 | 359 | 205 | 15 | SM00220 |
| Domain | PROTEIN_KINASE_ST | MARK1 OBSCN MAP3K1 RPS6KC1 MYO3A CDC42BPA LRRK1 ACVR1C TGFBR2 MAPK14 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 1.18e-05 | 362 | 205 | 15 | PS00108 |
| Domain | Pkinase | MARK1 OBSCN MAP3K1 RPS6KC1 MYO3A CDC42BPA LRRK1 ACVR1C TGFBR2 MAPK14 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 2.14e-05 | 381 | 205 | 15 | PF00069 |
| Domain | Integrin_b_cyt | 2.54e-05 | 6 | 205 | 3 | SM01241 | |
| Domain | Integrin_b_cyt | 2.54e-05 | 6 | 205 | 3 | PF08725 | |
| Domain | Integrin_bsu_cyt_dom | 2.54e-05 | 6 | 205 | 3 | IPR014836 | |
| Domain | Kinase-like_dom | SMG1 MARK1 OBSCN MAP3K1 RPS6KC1 MYO3A PI4KA CDC42BPA LRRK1 ACVR1C TGFBR2 MAPK14 MACF1 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 3.15e-05 | 542 | 205 | 18 | IPR011009 |
| Domain | Integrin_B_tail | 4.42e-05 | 7 | 205 | 3 | SM01242 | |
| Domain | Integrin_bsu_tail | 4.42e-05 | 7 | 205 | 3 | IPR012896 | |
| Domain | SWIM | 4.42e-05 | 7 | 205 | 3 | PF04434 | |
| Domain | Integrin_B_tail | 4.42e-05 | 7 | 205 | 3 | PF07965 | |
| Domain | INB | 7.01e-05 | 8 | 205 | 3 | SM00187 | |
| Domain | Integrin_bsu_VWA | 7.01e-05 | 8 | 205 | 3 | IPR002369 | |
| Domain | Integrin_beta | 7.01e-05 | 8 | 205 | 3 | PF00362 | |
| Domain | Integrin_bsu | 1.04e-04 | 9 | 205 | 3 | IPR015812 | |
| Domain | INTEGRIN_BETA | 1.04e-04 | 9 | 205 | 3 | PS00243 | |
| Domain | PSI_integrin | 1.04e-04 | 9 | 205 | 3 | PF17205 | |
| Domain | ZF_SWIM | 1.04e-04 | 9 | 205 | 3 | PS50966 | |
| Domain | Integin_beta_N | 1.04e-04 | 9 | 205 | 3 | IPR033760 | |
| Domain | Znf_SWIM | 1.04e-04 | 9 | 205 | 3 | IPR007527 | |
| Domain | DUF1220 | 1.04e-04 | 9 | 205 | 3 | SM01148 | |
| Domain | ClpS | 1.20e-04 | 2 | 205 | 2 | PF02617 | |
| Domain | ClpS_core | 1.20e-04 | 2 | 205 | 2 | IPR003769 | |
| Domain | PROTEIN_KINASE_ATP | MARK1 OBSCN MAP3K1 RPS6KC1 MYO3A CDC42BPA LRRK1 ACVR1C TGFBR2 MAPK14 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 1.74e-04 | 459 | 205 | 15 | PS00107 |
| Domain | Spectrin_repeat | 2.70e-04 | 29 | 205 | 4 | IPR002017 | |
| Domain | Prot_kinase_dom | MARK1 OBSCN MAP3K1 RPS6KC1 MYO3A CDC42BPA LRRK1 ACVR1C TGFBR2 MAPK14 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 3.42e-04 | 489 | 205 | 15 | IPR000719 |
| Domain | Ribosomal_L7/12_C/ClpS-like | 3.57e-04 | 3 | 205 | 2 | IPR014719 | |
| Domain | - | 3.57e-04 | 3 | 205 | 2 | 3.30.1390.10 | |
| Domain | PROTEIN_KINASE_DOM | MARK1 OBSCN MAP3K1 RPS6KC1 MYO3A CDC42BPA LRRK1 ACVR1C TGFBR2 MAPK14 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 3.73e-04 | 493 | 205 | 15 | PS50011 |
| Domain | ARM-type_fold | SMG1 NBEAL1 MAP3K1 TELO2 PI4KA STAG3L3 GCN1 ARFGEF1 ARFGEF3 RANBP17 PELP1 CTNNBL1 | 3.83e-04 | 339 | 205 | 12 | IPR016024 |
| Domain | SPEC | 3.98e-04 | 32 | 205 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.98e-04 | 32 | 205 | 4 | IPR018159 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.34e-04 | 14 | 205 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 4.34e-04 | 14 | 205 | 3 | IPR013602 | |
| Domain | DHC_N2 | 4.34e-04 | 14 | 205 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.34e-04 | 14 | 205 | 3 | IPR011704 | |
| Domain | AAA_8 | 4.34e-04 | 14 | 205 | 3 | PF12780 | |
| Domain | AAA_5 | 4.34e-04 | 14 | 205 | 3 | PF07728 | |
| Domain | WD40_repeat_dom | DCAF8 NBEAL1 CORO1C EML2 EDC4 WDR72 RBBP4 LRRK1 CORO1A WDHD1 DNAAF10 | 4.58e-04 | 297 | 205 | 11 | IPR017986 |
| Domain | DHC_fam | 5.38e-04 | 15 | 205 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 5.38e-04 | 15 | 205 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 5.38e-04 | 15 | 205 | 3 | IPR004273 | |
| Domain | DCB_dom | 7.09e-04 | 4 | 205 | 2 | IPR032629 | |
| Domain | - | 7.09e-04 | 4 | 205 | 2 | 1.20.5.630 | |
| Domain | Sec7_C | 7.09e-04 | 4 | 205 | 2 | IPR015403 | |
| Domain | DUF1981 | 7.09e-04 | 4 | 205 | 2 | PF09324 | |
| Domain | DCB | 7.09e-04 | 4 | 205 | 2 | PF16213 | |
| Domain | WD40 | DCAF8 NBEAL1 CORO1C EML2 EDC4 WDR72 RBBP4 CORO1A WDHD1 DNAAF10 | 7.82e-04 | 268 | 205 | 10 | SM00320 |
| Domain | WD40_repeat | DCAF8 NBEAL1 CORO1C EML2 EDC4 WDR72 RBBP4 CORO1A WDHD1 DNAAF10 | 8.76e-04 | 272 | 205 | 10 | IPR001680 |
| Domain | RUN | 9.42e-04 | 18 | 205 | 3 | SM00593 | |
| Domain | Protein_kinase_ATP_BS | MARK1 OBSCN MAP3K1 MYO3A CDC42BPA ACVR1C TGFBR2 MAPK14 MAPK1 MAPK11 MAPK13 MAP2K5 | 1.02e-03 | 379 | 205 | 12 | IPR017441 |
| Domain | WD_REPEATS_1 | DCAF8 NBEAL1 CORO1C EML2 EDC4 WDR72 RBBP4 CORO1A WDHD1 DNAAF10 | 1.03e-03 | 278 | 205 | 10 | PS00678 |
| Domain | WD_REPEATS_2 | DCAF8 NBEAL1 CORO1C EML2 EDC4 WDR72 RBBP4 CORO1A WDHD1 DNAAF10 | 1.06e-03 | 279 | 205 | 10 | PS50082 |
| Domain | WD_REPEATS_REGION | DCAF8 NBEAL1 CORO1C EML2 EDC4 WDR72 RBBP4 CORO1A WDHD1 DNAAF10 | 1.06e-03 | 279 | 205 | 10 | PS50294 |
| Domain | RUN | 1.11e-03 | 19 | 205 | 3 | PS50826 | |
| Domain | RUN | 1.11e-03 | 19 | 205 | 3 | PF02759 | |
| Domain | Run_dom | 1.11e-03 | 19 | 205 | 3 | IPR004012 | |
| Domain | Lysyl_oxidase | 1.17e-03 | 5 | 205 | 2 | IPR001695 | |
| Domain | LYSYL_OXIDASE | 1.17e-03 | 5 | 205 | 2 | PS00926 | |
| Domain | Lysyl_oxidase_CS | 1.17e-03 | 5 | 205 | 2 | IPR019828 | |
| Domain | Lysyl_oxidase | 1.17e-03 | 5 | 205 | 2 | PF01186 | |
| Domain | - | 1.32e-03 | 74 | 205 | 5 | 3.40.50.410 | |
| Domain | SRCR | 1.50e-03 | 21 | 205 | 3 | PF00530 | |
| Domain | - | 1.75e-03 | 6 | 205 | 2 | 3.90.1290.10 | |
| Domain | GAR | 1.75e-03 | 6 | 205 | 2 | PS51460 | |
| Domain | GAS2 | 1.75e-03 | 6 | 205 | 2 | PF02187 | |
| Domain | - | 1.75e-03 | 6 | 205 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 1.75e-03 | 6 | 205 | 2 | IPR003108 | |
| Domain | GAS2 | 1.75e-03 | 6 | 205 | 2 | SM00243 | |
| Domain | Spectrin | 1.96e-03 | 23 | 205 | 3 | PF00435 | |
| Domain | VWFA | 2.09e-03 | 82 | 205 | 5 | PS50234 | |
| Domain | WD40 | 2.31e-03 | 259 | 205 | 9 | PF00400 | |
| Domain | VWA | 2.32e-03 | 84 | 205 | 5 | SM00327 | |
| Domain | Pept_M16_Zn_BS | 2.43e-03 | 7 | 205 | 2 | IPR001431 | |
| Domain | Pept_M16_dom | 2.43e-03 | 7 | 205 | 2 | IPR011237 | |
| Domain | Metalloenz_LuxS/M16 | 2.43e-03 | 7 | 205 | 2 | IPR011249 | |
| Domain | Peptidase_M16 | 2.43e-03 | 7 | 205 | 2 | PF00675 | |
| Domain | Plectin | 2.43e-03 | 7 | 205 | 2 | PF00681 | |
| Domain | Trimer_CC | 2.43e-03 | 7 | 205 | 2 | IPR015049 | |
| Domain | DUF1899 | 2.43e-03 | 7 | 205 | 2 | IPR015048 | |
| Domain | Peptidase_M16_C | 2.43e-03 | 7 | 205 | 2 | IPR007863 | |
| Domain | TRPC_channel | 2.43e-03 | 7 | 205 | 2 | IPR002153 | |
| Domain | Trimer_CC | 2.43e-03 | 7 | 205 | 2 | PF08954 | |
| Domain | DUF1899 | 2.43e-03 | 7 | 205 | 2 | PF08953 | |
| Domain | ZnF_UBR1 | 2.43e-03 | 7 | 205 | 2 | SM00396 | |
| Domain | Plectin_repeat | 2.43e-03 | 7 | 205 | 2 | IPR001101 | |
| Domain | Coronin | 2.43e-03 | 7 | 205 | 2 | IPR015505 | |
| Domain | Peptidase_M16_C | 2.43e-03 | 7 | 205 | 2 | PF05193 | |
| Domain | Pept_M16_N | 2.43e-03 | 7 | 205 | 2 | IPR011765 | |
| Domain | ZF_UBR | 2.43e-03 | 7 | 205 | 2 | PS51157 | |
| Domain | - | 2.43e-03 | 7 | 205 | 2 | 3.30.830.10 | |
| Domain | zf-UBR | 2.43e-03 | 7 | 205 | 2 | PF02207 | |
| Domain | INSULINASE | 2.43e-03 | 7 | 205 | 2 | PS00143 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY | 2.60e-07 | 6 | 164 | 4 | M47766 | |
| Pathway | WP_MAPK_SIGNALING_PATHWAY | MAP3K1 ACVR1C PPM1A TGFBR2 RASGRP1 MAPK14 EGF MAPK1 IKBKB MAPK13 MAP2K5 | 2.63e-06 | 160 | 164 | 11 | MM15990 |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 1.36e-05 | 68 | 164 | 7 | M39456 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 1.44e-05 | 46 | 164 | 6 | M19118 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 1.44e-05 | 46 | 164 | 6 | MM1428 | |
| Pathway | WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING | 1.59e-05 | 28 | 164 | 5 | M39572 | |
| Pathway | WP_CANNABINOID_RECEPTOR_SIGNALING | 1.90e-05 | 29 | 164 | 5 | M39676 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 2.83e-05 | 76 | 164 | 7 | MM1433 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING | 3.73e-05 | 17 | 164 | 4 | M39686 | |
| Pathway | WP_CARDIAC_HYPERTROPHIC_RESPONSE | 4.09e-05 | 55 | 164 | 6 | M39685 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 4.28e-05 | 81 | 164 | 7 | M13863 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING | 5.65e-05 | 36 | 164 | 5 | M39908 | |
| Pathway | WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY | 6.47e-05 | 37 | 164 | 5 | M42558 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 6.75e-05 | 151 | 164 | 9 | M39801 | |
| Pathway | WP_INSULIN_SIGNALING | INPP4A MAP3K1 PTPN11 MAPK14 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 1.05e-04 | 160 | 164 | 9 | MM15956 |
| Pathway | WP_INSULIN_SIGNALING | INPP4A MAP3K1 PTPN11 MAPK14 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 1.05e-04 | 160 | 164 | 9 | M39482 |
| Pathway | BIOCARTA_NTHI_PATHWAY | 1.10e-04 | 22 | 164 | 4 | MM1443 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.11e-04 | 161 | 164 | 9 | M39770 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 1.11e-04 | 126 | 164 | 8 | M16763 | |
| Pathway | WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING | 1.32e-04 | 23 | 164 | 4 | M39709 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 1.32e-04 | 23 | 164 | 4 | M2821 | |
| Pathway | WP_MAPK_SIGNALING | MAP3K1 PPM1A TGFBR2 RASGRP1 MAPK14 EGF MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 1.43e-04 | 246 | 164 | 11 | M39597 |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.73e-04 | 71 | 164 | 6 | M15913 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.75e-04 | 10 | 164 | 3 | MM15135 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.75e-04 | 10 | 164 | 3 | M13962 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 1.85e-04 | 25 | 164 | 4 | M274 | |
| Pathway | KEGG_LEISHMANIA_INFECTION | 1.87e-04 | 72 | 164 | 6 | M3126 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY | 2.16e-04 | 26 | 164 | 4 | M47565 | |
| Pathway | BIOCARTA_EGFR_SMRTE_PATHWAY | 2.38e-04 | 11 | 164 | 3 | M18837 | |
| Pathway | BIOCARTA_EGFR_SMRTE_PATHWAY | 2.38e-04 | 11 | 164 | 3 | MM1432 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 2.51e-04 | 27 | 164 | 4 | M47755 | |
| Pathway | WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION | 2.51e-04 | 27 | 164 | 4 | M39838 | |
| Pathway | WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY | 2.53e-04 | 49 | 164 | 5 | M39543 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | MAP3K1 PPM1A TGFBR2 RASGRP1 MAPK14 EGF MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 2.92e-04 | 267 | 164 | 11 | M10792 |
| Pathway | WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ | 3.15e-04 | 12 | 164 | 3 | M39552 | |
| Pathway | WP_IL4_SIGNALING | 4.00e-04 | 54 | 164 | 5 | M39720 | |
| Pathway | WP_OSTEOPONTIN_SIGNALING | 4.06e-04 | 13 | 164 | 3 | M39603 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 4.06e-04 | 13 | 164 | 3 | M1441 | |
| Pathway | WP_IL1_SIGNALING | 4.36e-04 | 55 | 164 | 5 | M39346 | |
| Pathway | WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION | 5.55e-04 | 33 | 164 | 4 | M39745 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 6.24e-04 | 34 | 164 | 4 | M13881 | |
| Pathway | SIG_CD40PATHWAYMAP | 6.24e-04 | 34 | 164 | 4 | M12705 | |
| Pathway | WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY | 6.53e-04 | 60 | 164 | 5 | M39583 | |
| Pathway | KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY | 7.60e-04 | 62 | 164 | 5 | M15569 | |
| Pathway | PID_SMAD2_3PATHWAY | 7.74e-04 | 16 | 164 | 3 | M228 | |
| Pathway | REACTOME_NOD1_2_SIGNALING_PATHWAY | 7.78e-04 | 36 | 164 | 4 | M1059 | |
| Pathway | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | ABCC4 ITGB3 PTPN11 MAGED2 DAGLA APBB1IP RASGRP1 MAPK14 EGF MAPK1 | 8.56e-04 | 257 | 164 | 10 | MM15454 |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 8.65e-04 | 37 | 164 | 4 | MM14899 | |
| Pathway | BIOCARTA_HCMV_PATHWAY | 9.32e-04 | 17 | 164 | 3 | M8353 | |
| Pathway | BIOCARTA_HCMV_PATHWAY | 9.32e-04 | 17 | 164 | 3 | MM1408 | |
| Pathway | WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION | 9.32e-04 | 17 | 164 | 3 | M39907 | |
| Pathway | PID_FAS_PATHWAY | 9.58e-04 | 38 | 164 | 4 | M94 | |
| Pathway | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | ABCC4 ITGB3 PTPN11 MAGED2 DAGLA APBB1IP RASGRP1 MAPK14 EGF MAPK1 | 9.63e-04 | 261 | 164 | 10 | M1077 |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 9.68e-04 | 134 | 164 | 7 | M3574 | |
| Pathway | REACTOME_HEMOSTASIS | ABCC4 KIF26A ITGB1 ITGB2 ITGB3 PTPN11 MAGED2 DAGLA APBB1IP ADAMTS13 RASGRP1 MAPK14 EGF P2RX4 KIF4B MAPK1 | 1.02e-03 | 571 | 164 | 16 | MM14472 |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.06e-03 | 39 | 164 | 4 | MM14601 | |
| Pathway | BIOCARTA_41BB_PATHWAY | 1.11e-03 | 18 | 164 | 3 | M2064 | |
| Pathway | BIOCARTA_41BB_PATHWAY | 1.11e-03 | 18 | 164 | 3 | MM1511 | |
| Pathway | KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION | 1.16e-03 | 68 | 164 | 5 | M16848 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.16e-03 | 68 | 164 | 5 | MM14968 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.21e-03 | 102 | 164 | 6 | M3261 | |
| Pathway | PID_VEGFR1_2_PATHWAY | 1.24e-03 | 69 | 164 | 5 | M237 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 1.28e-03 | 103 | 164 | 6 | M39434 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 1.28e-03 | 41 | 164 | 4 | MM1493 | |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 1.31e-03 | 19 | 164 | 3 | MM14780 | |
| Pathway | REACTOME_SIGNAL_TRANSDUCTION_BY_L1 | 1.31e-03 | 19 | 164 | 3 | MM15113 | |
| Pathway | WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING | 1.47e-03 | 144 | 164 | 7 | M39691 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 1.48e-03 | 106 | 164 | 6 | M42535 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 1.52e-03 | 20 | 164 | 3 | M12256 | |
| Pathway | PID_CXCR3_PATHWAY | 1.53e-03 | 43 | 164 | 4 | M222 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.53e-03 | 43 | 164 | 4 | M47669 | |
| Pubmed | 4.28e-13 | 21 | 220 | 8 | 16079250 | ||
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 2.38e-09 | 10 | 220 | 5 | 22973535 | |
| Pubmed | NBPF12 ERCC6 ABCA13 MARK1 CORO1C RBKS STARD9 SLC25A11 NBPF14 NBPF8 FRAS1 NRCAM RBBP4 NBPF11 NBPF15 NBPF9 NBPF10 SNRNP200 | 5.84e-09 | 513 | 220 | 18 | 25798074 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ABCC4 SGSM1 DCAF8 INPP4A STARD10 TRPM2 OBSCN BCR ITGB1 TSPAN9 SGMS1 STAG3L1 UQCRC1 DENND5A ARHGEF37 ZSWIM4 DAGLA TRAPPC9 UBR2 CDC42BPA RBBP4 WWP1 FLVCR1 INTS8 ARFGEF3 RANBP17 LOXL2 MACF1 GREB1 CATSPERG VPS13B | 6.10e-09 | 1489 | 220 | 31 | 28611215 |
| Pubmed | UAP1 MARK1 CORO1C ACSL3 ACSL4 MMP24 UQCRC1 DNAH5 CDC42BPA PMPCB RBBP4 WWP1 PLCD4 PPM1A MAPK14 DNAH17 GALNT6 MAPK1 MAPK11 MAPK13 MAP2K5 | 9.93e-09 | 730 | 220 | 21 | 34857952 | |
| Pubmed | CORO1C TIPRL ITGB1 ACSL3 ACSL4 PTPN11 TELO2 PI4KA GCN1 UBR2 CDC42BPA PMPCB DSP FLVCR1 PPM1A MAPK14 NUP155 MTMR14 DNAAF10 SSX2IP SORBS3 MAPK1 MAPK11 G6PD | 6.56e-08 | 1049 | 220 | 24 | 27880917 | |
| Pubmed | F-box Protein βTrCP1 Is a Substrate of Extracellular Signal-regulated Kinase 2. | 1.07e-07 | 8 | 220 | 4 | 34703820 | |
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 23560844 | ||
| Pubmed | Increased Expressions of Integrin Subunit β1, β2 and β3 in Patients with Acute Infection. | 2.50e-07 | 3 | 220 | 3 | 26283883 | |
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 20501672 | ||
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 23857544 | ||
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 11825889 | ||
| Pubmed | 2.50e-07 | 3 | 220 | 3 | 21336470 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | UAP1 CORO1C SPTA1 STARD10 EDC4 PFKP EIF6 RYR1 SLC25A11 UQCRC1 GCN1 DSP SYNE1 EPG5 CORO1A FSD1L MACF1 PCNX1 G6PD SNRNP200 | 2.50e-07 | 807 | 220 | 20 | 30575818 |
| Pubmed | GON4L DNAH5 CDC42BPA DSP DIABLO RBBP4 SYNE1 PELP1 MACF1 SNRNP200 VPS13B | 3.35e-07 | 234 | 220 | 11 | 36243803 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | CORO1C ITGB1 ITGB2 ITGB3 PTPN11 FERMT2 GMPPB GCN1 CORO1A MAPK14 MAPK1 G6PD SNRNP200 | 3.49e-07 | 344 | 220 | 13 | 30333137 |
| Pubmed | GON4L ZBED4 STARD9 UBR2 FRAS1 NRCAM ZSWIM5 SYNE1 DLGAP4 EPG5 ARFGEF3 BAZ2A MACF1 VPS13B | 3.82e-07 | 407 | 220 | 14 | 12693553 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | KIF26A OBSCN EML2 EDC4 BCR EIF6 RYR1 ZBED4 PI4KA CCDC3 MLLT1 DENND5A GCN1 TRAPPC9 MED13 PNPLA2 FRAS1 CDC42BPA WWP1 LRRK1 MTMR14 SORBS3 PCNX1 | 6.51e-07 | 1105 | 220 | 23 | 35748872 |
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 20610565 | ||
| Pubmed | Role for mitogen-activated protein kinase p38 alpha in lung epithelial branching morphogenesis. | 9.94e-07 | 4 | 220 | 3 | 18177852 | |
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 21357746 | ||
| Pubmed | Coxsackie adenovirus receptor (CAR) regulates integrin function through activation of p44/42 MAPK. | 9.94e-07 | 4 | 220 | 3 | 19527712 | |
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 21325030 | ||
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 27235139 | ||
| Pubmed | Beta 1/beta 3 integrin ligation is uncoupled from ERK1/ERK2 activation in cytotoxic T lymphocytes. | 9.94e-07 | 4 | 220 | 3 | 12629153 | |
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 10066767 | ||
| Pubmed | Signaling mechanism of tumor cell-induced up-regulation of E3 ubiquitin ligase UBR2. | 9.94e-07 | 4 | 220 | 3 | 23568773 | |
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 12200131 | ||
| Pubmed | The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. | 1.07e-06 | 13 | 220 | 4 | 17906618 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DCAF8 TIPRL PFKP BCR ITGB1 LANCL2 ACSL3 PTPN11 DNAJC10 TELO2 GCN1 PMPCB POLD1 UBE2O MAPK14 NUP155 MTMR14 MAPK1 MAPK11 G6PD SNRNP200 | 1.18e-06 | 974 | 220 | 21 | 28675297 |
| Pubmed | 1.48e-06 | 14 | 220 | 4 | 18586681 | ||
| Pubmed | 1.48e-06 | 14 | 220 | 4 | 9373155 | ||
| Pubmed | 1.48e-06 | 14 | 220 | 4 | 12239168 | ||
| Pubmed | 1.48e-06 | 14 | 220 | 4 | 9687510 | ||
| Pubmed | MARK1 INPP4A CORO1C SPTA1 EDC4 PFKP BCR LANCL2 PI4KA LSM4 SLC25A11 UQCRC1 FERMT2 DAGLA TRAPPC9 NRCAM DSP SYNE1 DLGAP4 PLEKHA6 CORO1A UBE2O STON2 MACF1 MAPK1 SNRNP200 | 1.49e-06 | 1431 | 220 | 26 | 37142655 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UBR1 ERCC6 CORO1C PFKP EIF6 ACSL3 ACSL4 MAGED2 PI4KA SLC25A11 UQCRC1 FERMT2 GMPPB GCN1 PMPCB DSP RBBP4 POLD1 NUP155 BAZ2A CTNNBL1 MACF1 MAPK1 G6PD SNRNP200 | 1.79e-06 | 1353 | 220 | 25 | 29467282 |
| Pubmed | Kindlin-2 controls TGF-β signalling and Sox9 expression to regulate chondrogenesis. | 2.01e-06 | 15 | 220 | 4 | 26151572 | |
| Pubmed | PRAK, a novel protein kinase regulated by the p38 MAP kinase. | 2.01e-06 | 15 | 220 | 4 | 9628874 | |
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 18487214 | ||
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 15632108 | ||
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 17304211 | ||
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 10698974 | ||
| Pubmed | SMG1 OBSCN GON4L ITGB1 RYR1 PTPN11 ADAMTS9 MED13 CDC42BPA DSP SYNE1 WWP1 MTMR14 MACF1 | 3.97e-06 | 497 | 220 | 14 | 23414517 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | CORO1C EDC4 LANCL2 EIF6 ACSL3 PTPN11 MAGED2 STARD9 PI4KA SLC25A11 UQCRC1 DNAH5 GCN1 PMPCB DSP DIABLO RBBP4 POLD1 SYNE1 UBE2O NUP155 PELP1 CTNNBL1 G6PD SNRNP200 | 4.45e-06 | 1425 | 220 | 25 | 30948266 |
| Pubmed | Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer's mice. | 4.92e-06 | 6 | 220 | 3 | 27856911 | |
| Pubmed | Bidirectional regulation of neutrophil migration by mitogen-activated protein kinases. | 4.92e-06 | 6 | 220 | 3 | 22447027 | |
| Pubmed | 4.92e-06 | 6 | 220 | 3 | 14680475 | ||
| Pubmed | 4.92e-06 | 6 | 220 | 3 | 19656390 | ||
| Pubmed | HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes. | 4.92e-06 | 6 | 220 | 3 | 8757599 | |
| Pubmed | BCR MAP3K1 PTPN11 ACVR1C PPM1A MAPK14 EGF MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 4.94e-06 | 371 | 220 | 12 | 25241761 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | BCR DNAJC10 MAGED2 PI4KA GCN1 PMPCB POLD1 WWP1 ARFGEF3 WDHD1 SNRNP200 | 5.65e-06 | 313 | 220 | 11 | 38270169 |
| Pubmed | ABCC4 EDC4 PFKP BCR ITGB1 ITGB2 ACSL3 ACSL4 SGMS1 DNAJC10 ARL6IP1 MAGED2 PI4KA GCN1 MED13 POLD1 CORO1A NUP155 P2RX4 PELP1 CTNNBL1 G6PD | 5.75e-06 | 1168 | 220 | 22 | 19946888 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | SMG1 MARK1 BCR EIF6 MAP3K1 MLLT1 POGLUT2 CDC42BPA RBBP4 MAPK14 EGF STON2 FIBP MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 G6PD | 6.14e-06 | 910 | 220 | 19 | 36736316 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | UBR1 UAP1 CORO1C TIPRL PFKP ITGB1 ENOPH1 ACSL3 ACSL4 PTPN11 MAGED2 SLC25A11 GMPPB GCN1 ALDH5A1 DSP DIABLO ARFGEF1 UBE2O NUP155 PELP1 CTNNBL1 MAPK1 G6PD | 6.92e-06 | 1367 | 220 | 24 | 32687490 |
| Pubmed | 6.97e-06 | 20 | 220 | 4 | 11438667 | ||
| Pubmed | PFKP LANCL2 MAP3K1 ACSL3 MYO3A DNAJC10 MAGED2 SLC25A11 UQCRC1 GCN1 DSP SYNE1 PELP1 MACF1 IAH1 MAPK1 G6PD SNRNP200 | 8.17e-06 | 844 | 220 | 18 | 25963833 | |
| Pubmed | Association of human platelet alloantigen 1 through 5 polymorphisms with ischemic stroke. | 8.58e-06 | 7 | 220 | 3 | 18057877 | |
| Pubmed | Knockout of ERK5 causes multiple defects in placental and embryonic development. | 8.58e-06 | 7 | 220 | 3 | 14675480 | |
| Pubmed | A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. | 8.58e-06 | 7 | 220 | 3 | 19234460 | |
| Pubmed | p38 MAPK signalling cascades: ancient roles and new functions. | 8.58e-06 | 7 | 220 | 3 | 10878576 | |
| Pubmed | Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. | 8.58e-06 | 7 | 220 | 3 | 16636664 | |
| Pubmed | 8.58e-06 | 7 | 220 | 3 | 9256245 | ||
| Pubmed | 8.58e-06 | 7 | 220 | 3 | 17182689 | ||
| Pubmed | 8.58e-06 | 7 | 220 | 3 | 31178125 | ||
| Pubmed | DCAF8 PFKP ITGB1 EIF6 NCBP3 ACSL3 DNAJC10 TELO2 PI4KA LSM4 FERMT2 FRAS1 CDC42BPA PMPCB RBBP4 POLD1 SYNE1 FLVCR1 UBE2O NUP155 BAZ2A SSX2IP MACF1 SNRNP200 VPS13B | 9.23e-06 | 1487 | 220 | 25 | 33957083 | |
| Pubmed | Subdomain VIII is a specificity-determining region in MEKK1. | 1.37e-05 | 8 | 220 | 3 | 14500727 | |
| Pubmed | Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. | 1.37e-05 | 8 | 220 | 3 | 9155017 | |
| Pubmed | 1.37e-05 | 8 | 220 | 3 | 10801826 | ||
| Pubmed | 1.37e-05 | 8 | 220 | 3 | 8649427 | ||
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | DCAF8 TIPRL LANCL2 ACSL3 MAGED2 TELO2 PI4KA SLC25A11 UQCRC1 GCN1 PPM1A UBE2O NUP155 MAPK1 | 1.88e-05 | 571 | 220 | 14 | 37167062 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | DCAF8 CORO1C EDC4 PFKP EIF6 PTPN11 MAGED2 TELO2 FERMT2 GMPPB GCN1 DIABLO RBBP4 POLD1 DYNLT3 UBE2O MAPK14 NUP155 WDHD1 DNAAF10 MACF1 IKBKB G6PD SNRNP200 | 1.92e-05 | 1455 | 220 | 24 | 22863883 |
| Pubmed | 2.04e-05 | 9 | 220 | 3 | 23555914 | ||
| Pubmed | Molecular profiles of mitogen activated protein kinase signaling pathways in orofacial development. | 2.09e-05 | 26 | 220 | 4 | 17177285 | |
| Pubmed | 2.44e-05 | 27 | 220 | 4 | 19026994 | ||
| Pubmed | DCAF8 CORO1C SPTA1 OBSCN PI4KA FERMT2 RBBP4 NUP155 IKBKB SNRNP200 | 2.66e-05 | 304 | 220 | 10 | 32235678 | |
| Pubmed | 2.90e-05 | 10 | 220 | 3 | 15192046 | ||
| Pubmed | Gab1 is an integrator of cell death versus cell survival signals in oxidative stress. | 2.90e-05 | 10 | 220 | 3 | 12808090 | |
| Pubmed | Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. | 2.90e-05 | 10 | 220 | 3 | 9199504 | |
| Pubmed | USP7 controls NGN3 stability and pancreatic endocrine lineage development. | 3.38e-05 | 58 | 220 | 5 | 37117185 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | CORO1C EDC4 TIPRL PFKP ITGB1 PTPN11 DNAJC10 UQCRC1 GCN1 PMPCB CORO1A NUP155 MAPK1 SNRNP200 | 3.67e-05 | 607 | 220 | 14 | 39147351 |
| Pubmed | HIV-1 inhibits autophagy in bystander macrophage/monocytic cells through Src-Akt and STAT3. | 3.97e-05 | 11 | 220 | 3 | 20661303 | |
| Pubmed | 3.97e-05 | 11 | 220 | 3 | 17996703 | ||
| Pubmed | Fasting-induced activation of mitogen-activated protein kinases (ERK/p38) in the mouse hypothalamus. | 3.98e-05 | 2 | 220 | 2 | 14763996 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 31996711 | ||
| Pubmed | β3 integrin is dispensable for conditioned fear and hebbian forms of plasticity in the hippocampus. | 3.98e-05 | 2 | 220 | 2 | 22748100 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 23185472 | ||
| Pubmed | Role of N-end rule ubiquitin ligases UBR1 and UBR2 in regulating the leucine-mTOR signaling pathway. | 3.98e-05 | 2 | 220 | 2 | 20298436 | |
| Pubmed | Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1. | 3.98e-05 | 2 | 220 | 2 | 29511213 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 22511753 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 20587417 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 16177070 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 31071912 | ||
| Pubmed | The beta1 and beta3 integrins promote T cell receptor-mediated cytotoxic T lymphocyte activation. | 3.98e-05 | 2 | 220 | 2 | 12690105 | |
| Pubmed | The p38alpha/beta MAPK functions as a molecular switch to activate the quiescent satellite cell. | 3.98e-05 | 2 | 220 | 2 | 15824134 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 32286604 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 16415171 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 27486885 | ||
| Pubmed | Tyrosine phosphatase SHP2 regulates the expression of acyl-CoA synthetase ACSL4. | 3.98e-05 | 2 | 220 | 2 | 21903867 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 24531379 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 31896114 | ||
| Cytoband | 1q21.1 | 1.22e-05 | 62 | 219 | 5 | 1q21.1 | |
| GeneFamily | Neuroblastoma breakpoint family | NBPF12 NBPF26 NBPF19 NBPF14 NBPF8 NBPF11 NBPF15 NBPF9 NBPF10 | 1.74e-13 | 23 | 158 | 9 | 662 |
| GeneFamily | Mitogen-activated protein kinases | 3.78e-06 | 13 | 158 | 4 | 651 | |
| GeneFamily | Dyneins, axonemal | 1.22e-05 | 17 | 158 | 4 | 536 | |
| GeneFamily | Zinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases | 5.29e-05 | 9 | 158 | 3 | 90 | |
| GeneFamily | CD molecules|Integrin beta subunits | 5.29e-05 | 9 | 158 | 3 | 1159 | |
| GeneFamily | WD repeat domain containing | 5.05e-04 | 262 | 158 | 9 | 362 | |
| GeneFamily | Lipases|Arylacetamide deacetylase family | 8.93e-04 | 22 | 158 | 3 | 464 | |
| GeneFamily | WD repeat domain containing|Coronins | 1.55e-03 | 7 | 158 | 2 | 495 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 1.55e-03 | 7 | 158 | 2 | 785 | |
| GeneFamily | Transient receptor potential cation channels | 1.83e-03 | 28 | 158 | 3 | 249 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.05e-03 | 8 | 158 | 2 | 939 | |
| GeneFamily | Classical BAR domain containing | 2.05e-03 | 8 | 158 | 2 | 1292 | |
| GeneFamily | Complement system|Sushi domain containing | 3.78e-03 | 36 | 158 | 3 | 492 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 5.56e-03 | 13 | 158 | 2 | 170 | |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | NR2C1 STAG3L1 APBB1IP SYNE1 WWP1 INTS8 LIPT1 MAPK14 BAZ2A MACF1 | 6.46e-06 | 199 | 216 | 10 | M7607 |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN | CORO1C ENOPH1 ARL6IP1 POLD1 WNT8A ICA1 MAPK14 WDHD1 MTMR14 GALNT6 | 6.75e-06 | 200 | 216 | 10 | M9310 |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_669C_3P_GENES | TRAPPC9 CDC42BPA DLGAP4 ZNF563 MAPK14 BAZ2A EGR3 GREB1 IKBKB | 2.24e-05 | 183 | 216 | 9 | MM17506 |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 2.69e-05 | 144 | 216 | 8 | M5942 | |
| Coexpression | GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 4.15e-05 | 198 | 216 | 9 | M7610 | |
| Coexpression | GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP | 4.48e-05 | 200 | 216 | 9 | M3251 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_DN | 4.48e-05 | 200 | 216 | 9 | M9925 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_DN | 4.48e-05 | 200 | 216 | 9 | M6634 | |
| Coexpression | GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | 4.48e-05 | 200 | 216 | 9 | M6533 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | EPOR ABCC4 BTBD6 NBPF12 INPP4A TRPM2 NBPF26 MAP3K1 MYO3A ARL6IP1 MAGED2 ADAMTS9 DENND5A FERMT2 NBPF14 KLF11 NRCAM DSP DIABLO ZSWIM5 FOLR1 PLEKHA6 NBPF11 NBPF15 EGF P2RX4 SORBS3 GREB1 IAH1 | 2.97e-06 | 1153 | 208 | 29 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-07 | 175 | 218 | 9 | 41174b7381932a2cc94063c7202eeff6d3208cc7 | |
| ToppCell | Secretory|World / shred by cell class for bronchial biopsy | GALNT3 ABCA13 INSIG1 STARD10 ACSL3 DNAJC10 MAGED2 ARFGEF3 GALNT6 | 5.33e-07 | 195 | 218 | 9 | 52f8281fe0df67cec3faa780a23ed6343ed5a6ba |
| ToppCell | moderate-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.06e-07 | 198 | 218 | 9 | 7ecce5e266bb08797088cc8f8309e0c7b48df5c9 | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.59e-07 | 200 | 218 | 9 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.59e-07 | 200 | 218 | 9 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.59e-07 | 200 | 218 | 9 | d5426cd318a8f90c0bd8f9804351ab230fafc995 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.59e-07 | 200 | 218 | 9 | 21d9cf3cd3696ad6b745c7c036798f04b6ce5160 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.59e-07 | 200 | 218 | 9 | 33658d5d09e2eaff60f4dd88837d4252328eab63 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.83e-06 | 168 | 218 | 8 | 2d056cfbb470a088a0682576753535fb4528d48f | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.83e-06 | 168 | 218 | 8 | 2f69e248c6fab1421c0081e01e1920e6ffcde344 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.05e-06 | 187 | 218 | 8 | 46e15419e80bd7180f3171a99d845b01bb635e53 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.05e-06 | 187 | 218 | 8 | 0d17b07770e4c881a7ca53a5bd42471457d198fb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.05e-06 | 187 | 218 | 8 | 69068480f6819a6c8560ecbb05deb156b4055e12 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.05e-06 | 187 | 218 | 8 | 9c8b932a15b8b50982cba4cf8db750e257eb9503 | |
| ToppCell | 15-Distal-Epithelial-Secretory_progenitor|Distal / Age, Tissue, Lineage and Cell class | 4.21e-06 | 188 | 218 | 8 | 9a64fb07de611de38d6f24673feb3b81a5e85384 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-hematopoietic_progenitor-common_myeloid_progenitor|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.38e-06 | 189 | 218 | 8 | 56156325cc36b1329bf483f81bb74f371ef15e20 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-06 | 189 | 218 | 8 | 5a0fd34928117f162c83ca1b068aa8f7069a6765 | |
| ToppCell | 21-Trachea-Immune-Immune|Trachea / Age, Tissue, Lineage and Cell class | 4.44e-06 | 134 | 218 | 7 | 4f0465324cc5b443ebadb68aef63be79b74f6ff9 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 4.55e-06 | 190 | 218 | 8 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.55e-06 | 190 | 218 | 8 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.73e-06 | 191 | 218 | 8 | bce138f067b8962ecef1ddec6511a3f142d81d78 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.92e-06 | 192 | 218 | 8 | 4e3deefd30adb7bf1eba294610eed3d077aa9418 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.11e-06 | 193 | 218 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-06 | 194 | 218 | 8 | 0797245ebfa389a6f66874cb0f11297f1456e600 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-06 | 194 | 218 | 8 | 0241b4b88d6210b4c1b8aa99db17115b18142f01 | |
| ToppCell | 15-Airway-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 5.51e-06 | 195 | 218 | 8 | cd0af7e260e4f0c5a9ecdfa93619f37b2a9308a5 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Mucous-Mucous|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.72e-06 | 196 | 218 | 8 | 357a5440aeebf69688bfe9fbc8585950ad00906b | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Mucous|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.72e-06 | 196 | 218 | 8 | 98e3f9c886063def16c74ab75fc81511a7872f1c | |
| ToppCell | moderate-Epithelial-Secretory|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.17e-06 | 198 | 218 | 8 | 7d96d7105a849c7280ce87bd76ce130ac47384fd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.17e-06 | 198 | 218 | 8 | d5e125f0c4f41b47d567568d0838adcca7655f6d | |
| ToppCell | cellseq2-Epithelial|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.40e-06 | 199 | 218 | 8 | 2d4fb558845764f937efaf39962caaeb2c85478b | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.40e-06 | 199 | 218 | 8 | ca78fd6e310232b25b864ed02ff9242fe1aa8206 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-SPP1+_Mac|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.40e-06 | 199 | 218 | 8 | d94cf750599366061066074e8007d707adf6fc5a | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.64e-06 | 200 | 218 | 8 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.64e-06 | 200 | 218 | 8 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 6.64e-06 | 200 | 218 | 8 | be83f442179ba4217d12f0458059586ff3130991 | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass | 6.64e-06 | 200 | 218 | 8 | 3813fa1ee1462ba83fd8b6253070f46f0b063084 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.32e-06 | 150 | 218 | 7 | 6f7087a051a2f05c5611ff65a945c01736d5ec2b | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-05 | 154 | 218 | 7 | 43735f7c58cac51855ded486ee8d8729a1b9909e | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-05 | 154 | 218 | 7 | d55fb73461885e1e02061a344ff89624ef4de487 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-05 | 166 | 218 | 7 | c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Secretory/RAS|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.10e-05 | 170 | 218 | 7 | b62f7184e78e9672ea88e361654f604f9df2dc5f | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.10e-05 | 170 | 218 | 7 | 00fe77bca9c28762212c498f9c49e14cb1492cca | |
| ToppCell | (7)_MNP-(7)_DC_activated|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.10e-05 | 170 | 218 | 7 | 4ab495b38a071fa8207331df2ce0d78a2dcd034e | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.18e-05 | 171 | 218 | 7 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | (9)_Platelet|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.72e-05 | 177 | 218 | 7 | e63d01c7fce4fa1256212fa7e95f74281edb3a01 | |
| ToppCell | (9)_Platelet|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.72e-05 | 177 | 218 | 7 | 0830944c43de300815831a9e2b2fce40965e7d12 | |
| ToppCell | COVID-19_Convalescent-PLT_1|World / Disease Group and Platelet Clusters | 2.92e-05 | 179 | 218 | 7 | d0f2764c6fc5d61fd69e9231b3603a80ac373f65 | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.03e-05 | 180 | 218 | 7 | c3c72531af5b9f7a7416727fe609dab5180e03b6 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous-SMG_mucous_L.0.6.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.03e-05 | 180 | 218 | 7 | 8af51245ac1269f318268f574cfaddb0b8c80a53 | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell-B_activate-7|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.03e-05 | 180 | 218 | 7 | 9f4bbaf6435c23e3e552ae22be8ea7884314192d | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.03e-05 | 180 | 218 | 7 | b465f2f8b0e9a2034a4f1272bb00c77439164dbf | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.25e-05 | 182 | 218 | 7 | dc32f8f6a3b13918eb8e93c018f5823d86344080 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.25e-05 | 182 | 218 | 7 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.25e-05 | 182 | 218 | 7 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 183 | 218 | 7 | ee9c88be88221b7ad4ea9f890b17d6156fb3432e | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 183 | 218 | 7 | c52b84034503d931f7b87312d2ff86daff14152d | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.36e-05 | 183 | 218 | 7 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 184 | 218 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | control-Others|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.48e-05 | 184 | 218 | 7 | a63b39fcc570b554cf10e8e47c2c1e079034768f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 184 | 218 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | control-Others-Megakaryocytes|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.48e-05 | 184 | 218 | 7 | 213915f2889ce8ecbe5f7b19bc2b24ed8c5efe1d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 184 | 218 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.60e-05 | 185 | 218 | 7 | af078a6c4a3e0b54b7d8ab7b30dcd06053ebfd28 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.60e-05 | 185 | 218 | 7 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.60e-05 | 185 | 218 | 7 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.60e-05 | 185 | 218 | 7 | 709236097cbfc254796fcc69b5f5178b73dad9bd | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.60e-05 | 185 | 218 | 7 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.73e-05 | 186 | 218 | 7 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.73e-05 | 186 | 218 | 7 | 6d8dd6d0403d149cb6edb346581fe6c248036785 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.73e-05 | 186 | 218 | 7 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.73e-05 | 186 | 218 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 3.86e-05 | 187 | 218 | 7 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | ASK440-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.13e-05 | 189 | 218 | 7 | 72a19b20cb0f7283afe5f85d62a21cff69fd78d0 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.13e-05 | 189 | 218 | 7 | 8777a341dd4f02ac5ee45c6c489ce74f4c87ce15 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous-SMG_mucous_L.0.6.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.13e-05 | 189 | 218 | 7 | 86d751cca35c42067157e218567daf9ab9d5f907 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.13e-05 | 189 | 218 | 7 | ccc5436ef22016559bfdaca12b9ab5ce8d5944b1 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.27e-05 | 190 | 218 | 7 | e5625feb21915d4545cfad2659745ef180efcb1f | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.27e-05 | 190 | 218 | 7 | 081b7bc07b6e5685e8a91b9ae6c1141623723700 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.27e-05 | 190 | 218 | 7 | 912aa106581d1ed7e147c92f9a367e8e6b04052b | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-AT1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.37e-05 | 130 | 218 | 6 | eb16a8f8f62add5fdd29c78d4608b6d1a06767f1 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 191 | 218 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | (3)_MNP-(3)_DC_activated|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.41e-05 | 191 | 218 | 7 | 0353bf797c4ef237b9bb82460c173c7d03cb8883 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 191 | 218 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.41e-05 | 191 | 218 | 7 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 191 | 218 | 7 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.56e-05 | 192 | 218 | 7 | a22952b885c8a7704a4a9602fa03e4f2c786bf75 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.56e-05 | 192 | 218 | 7 | dcf2d0c2e8868104c4dba410456207f0d947029a | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-05 | 192 | 218 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.56e-05 | 192 | 218 | 7 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.56e-05 | 192 | 218 | 7 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_proliferating_myeloid_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.56e-05 | 192 | 218 | 7 | 7e7383093efaadceadd4d1f900c2d39cd690102e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.56e-05 | 192 | 218 | 7 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 4.56e-05 | 192 | 218 | 7 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 4.71e-05 | 193 | 218 | 7 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 4.71e-05 | 193 | 218 | 7 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 4.71e-05 | 193 | 218 | 7 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.71e-05 | 193 | 218 | 7 | b25cdca3a1e381784ae48ca73c51cbb6ac62b811 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.71e-05 | 193 | 218 | 7 | b38aaffbea36ef6c08ebe82675438f873c89b242 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.71e-05 | 193 | 218 | 7 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| Drug | vanadyl | MAP3K1 PTPN11 AGTR2 DNAH5 DNAH8 ARFGEF1 MAPK14 EGF DNAAF10 DNAH17 MAPK1 MAPK11 MAPK13 MAP2K5 G6PD | 2.37e-07 | 307 | 214 | 15 | CID000061671 |
| Drug | methyl ethyl ketone | UBR1 EPOR AVPR1A MARK1 BCR ITGB1 ITGB3 MAP3K1 RPS6KC1 PTPN11 AGTR2 DIABLO MAPK14 EGF DNAAF10 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 7.80e-07 | 587 | 214 | 20 | CID000006569 |
| Drug | methylamine | CFH BCR LOXL4 C2 KIR3DL1 ALDH5A1 SYNE1 LIPT1 EGF DNAAF10 LOXL2 VPS13B | 1.37e-06 | 222 | 214 | 12 | CID000006329 |
| Drug | C11102 | 1.51e-06 | 86 | 214 | 8 | CID000443069 | |
| Drug | wartmannin | EPOR TRPC5 ITGB1 ITGB2 ITGB3 MAP3K1 RPS6KC1 MYO3A PTPN11 PI4KA AGTR2 C2 DAGLA HTR1F GDF15 MAPK14 EGF P2RX4 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 2.62e-06 | 811 | 214 | 23 | CID000005691 |
| Drug | AC1L1KMJ | SPTA1 TRPC5 ITGB1 ITGB2 ITGB3 MAP3K1 PI4KA FOLR1 MAPK14 EGF SSX2IP MACF1 MAPK1 IKBKB MAPK11 MAPK13 VPS13B | 2.90e-06 | 476 | 214 | 17 | CID000030956 |
| Drug | Ac2-26 | 3.25e-06 | 4 | 214 | 3 | CID000568638 | |
| Drug | NSC-68458 | 3.25e-06 | 4 | 214 | 3 | CID000249771 | |
| Drug | MDL-28842 | 3.54e-06 | 12 | 214 | 4 | CID006441200 | |
| Drug | SB202474 | 7.06e-06 | 14 | 214 | 4 | CID000005162 | |
| Drug | 2-(2,6-dioxopiperidin-3-yl)phthalimidine | 8.08e-06 | 5 | 214 | 3 | ctd:C001079 | |
| Drug | SB203580 | MARK1 BCR ITGB2 MAP3K1 RPS6KC1 MMP24 PTPN11 ADAMTS9 AGTR2 DIABLO WNT8A ACVR1C MAPK14 EGF P2RX4 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 VPS13B | 1.35e-05 | 771 | 214 | 21 | CID000176155 |
| Drug | Protriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | INPP4A INSIG1 TRPM2 ITGB3 DENND5B GDF15 SNCAIP EGR3 GREB1 MAPK11 | 1.39e-05 | 191 | 214 | 10 | 6498_UP |
| Drug | U0126 | BCR ITGB1 MAP3K1 RPS6KC1 PTPN11 KLF11 DIABLO TGFBR2 MAPK14 EGF DNAAF10 MAPK1 MAPK11 MAPK13 MAP2K5 | 1.49e-05 | 430 | 214 | 15 | CID000005637 |
| Drug | arachidonic acid trifluoromethyl ketone | 1.50e-05 | 153 | 214 | 9 | CID000002224 | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | ABCC4 DCAF8 BRCA1 ZBED4 FERMT2 UBR2 SORBS3 MACF1 IKBKB MAPK11 | 1.60e-05 | 194 | 214 | 10 | 1670_DN |
| Drug | Sulfaguanidine [57-67-0]; Down 200; 18.6uM; MCF7; HT_HG-U133A | EPOR ABCC4 DCAF8 BCR ITGB1 PLEKHA6 SSX2IP IKBKB MAPK11 MAP2K5 | 1.60e-05 | 194 | 214 | 10 | 4839_DN |
| Drug | tolyltriazole | 1.60e-05 | 6 | 214 | 3 | CID000025902 | |
| Drug | kazinol B | 1.64e-05 | 17 | 214 | 4 | CID000480869 | |
| Drug | Estradiol-17 beta [50-28-2]; Up 200; 14.6uM; MCF7; HT_HG-U133A | NR2C1 ITGB1 ITGB3 MAP3K1 CDC42BPA DLGAP4 ARFGEF1 BLZF1 WDHD1 EGR3 | 1.67e-05 | 195 | 214 | 10 | 2653_UP |
| Drug | AC1L1CFC | 1.73e-05 | 58 | 214 | 6 | CID000001874 | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | INPP4A GON4L EDC4 BCR TSPAN9 BRCA1 CORO1A BAZ2A MACF1 MAPK13 | 1.82e-05 | 197 | 214 | 10 | 4774_DN |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A | EPOR RBKS ITGB2 BTN2A2 BRCA1 CORO1A MAPK14 LOXL2 SORBS3 PCNX1 | 1.82e-05 | 197 | 214 | 10 | 4544_DN |
| Drug | AC1L1J0H | ITGB1 ITGB2 MAP3K1 KIR3DL1 MAPK14 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 1.82e-05 | 197 | 214 | 10 | CID000004813 |
| Drug | Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A | EPOR ABCC4 EML2 OSGEPL1 ALDH5A1 DLGAP4 PEX26 MAPK14 BAZ2A MAP2K5 | 1.82e-05 | 197 | 214 | 10 | 7478_DN |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | GALNT3 TRPM2 EML2 RYR1 ADAMTS9 CA9 CDC42BPA ICA1 DLGAP4 SNCAIP | 1.82e-05 | 197 | 214 | 10 | 3940_UP |
| Drug | Ampicillin trihydrate [7177-48-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.82e-05 | 197 | 214 | 10 | 5408_DN | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; HL60; HT_HG-U133A | EPOR RBKS OSGEPL1 ALDH5A1 BLZF1 MAPK14 ZKSCAN1 BAZ2A MACF1 MAP2K5 | 1.90e-05 | 198 | 214 | 10 | 2345_DN |
| Drug | Propranolol hydrochloride [318-98-9]; Down 200; 13.6uM; MCF7; HT_HG-U133A | DOK5 INPP4A THSD1 TSPAN9 ALDH5A1 DAGLA DENND5B BLZF1 PEX26 DNAH17 | 1.90e-05 | 198 | 214 | 10 | 3396_DN |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; HL60; HT_HG-U133A | ABCC4 BTN2A2 PTPN11 PNPLA2 DLGAP4 BLZF1 PPM1A P2RX4 WDHD1 MAP2K5 | 1.99e-05 | 199 | 214 | 10 | 2546_DN |
| Drug | Betulin [473-98-3]; Down 200; 9uM; MCF7; HT_HG-U133A | NR2C1 EML2 ITGB1 MAP3K1 ZBED4 OSGEPL1 PNPLA2 CDC42BPA SSX2IP MAPK13 | 1.99e-05 | 199 | 214 | 10 | 7454_DN |
| Drug | Clioquinol [130-26-7]; Down 200; 13uM; MCF7; HT_HG-U133A | EPOR TRPC5 MAP3K1 ACSL4 TRAPPC9 SORBS3 PCNX1 IKBKB MAPK11 MAP2K5 | 1.99e-05 | 199 | 214 | 10 | 5623_DN |
| Drug | Acemetacin [53164-05-9]; Down 200; 9.6uM; PC3; HT_HG-U133A | EPOR NR2C1 ITGB1 BTN2A2 ZBED4 TELO2 DAGLA PEX26 MAPK14 SORBS3 | 1.99e-05 | 199 | 214 | 10 | 6361_DN |
| Drug | hexitol | CFH MAP3K1 LSM4 GMPPB DIABLO MAPK14 MAPK1 MAPK11 MAPK13 MAP2K5 G6PD | 2.03e-05 | 243 | 214 | 11 | CID000000453 |
| Drug | pyridinyl imidazole | 2.08e-05 | 36 | 214 | 5 | CID000005171 | |
| Drug | Cp-38 | 2.79e-05 | 7 | 214 | 3 | CID006918286 | |
| Drug | satratoxin H | 2.79e-05 | 7 | 214 | 3 | CID000434380 | |
| Drug | 2,2',4,6-tetrachlorobiphenyl | 2.79e-05 | 7 | 214 | 3 | CID000044163 | |
| Drug | CID6325568 | 2.79e-05 | 7 | 214 | 3 | CID006325568 | |
| Drug | LY294002 | EPOR PFKP BCR ITGB1 ITGB2 RPS6KC1 MMP24 MYO3A PTPN11 PI4KA DIABLO GDF15 AKAP3 MAPK14 EGF MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 2.83e-05 | 748 | 214 | 20 | CID000003973 |
| Drug | MnTMPyP | 3.11e-05 | 39 | 214 | 5 | CID000004233 | |
| Drug | compound 9b | 3.27e-05 | 20 | 214 | 4 | CID000207510 | |
| Drug | n-sulfo-2-aminotricarballylate | 3.27e-05 | 20 | 214 | 4 | CID000135808 | |
| Drug | Leu-asp-val | 3.27e-05 | 20 | 214 | 4 | CID000130816 | |
| Drug | AC1L1JM9 | ITGB1 ITGB2 MAP3K1 IFNA6 RASGRP1 MAPK14 EGF MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 3.31e-05 | 304 | 214 | 12 | CID000005103 |
| Drug | dhS1P | 3.34e-05 | 65 | 214 | 6 | CID000000520 | |
| Drug | Go6983 | 3.52e-05 | 40 | 214 | 5 | CID000003499 | |
| Drug | DB04790 | 3.52e-05 | 40 | 214 | 5 | CID005326924 | |
| Drug | SF6847 | 3.98e-05 | 41 | 214 | 5 | CID000005614 | |
| Drug | L0168 | 4.01e-05 | 21 | 214 | 4 | CID000445856 | |
| Drug | Z-D-CH2DCB | 4.43e-05 | 8 | 214 | 3 | CID009911778 | |
| Drug | ML3403 | 4.43e-05 | 8 | 214 | 3 | CID006419739 | |
| Drug | Bortezomib | ABCC4 OBSCN BCR RPS6KC1 PTPN11 SGMS1 BRCA1 LSM4 SLC25A11 KIR3DS1 ALDH5A1 CA9 DIABLO FOLR1 GDF15 PPM1A FSD1L MAPK14 MAPK1 IKBKB G6PD | 4.55e-05 | 838 | 214 | 21 | ctd:D000069286 |
| Drug | eye gene | EPOR MAP3K1 MYO3A AGTR2 LOXL4 C2 PLCD4 MAPK14 EGF LOXL2 MAPK1 MAPK11 MAPK13 | 5.04e-05 | 369 | 214 | 13 | CID000004782 |
| Drug | genistein | EPOR ABCC4 INSIG1 EDC4 ITGB1 ITGB2 ITGB3 RYR1 RPS6KC1 MMP24 PTPN11 BRCA1 TELO2 MLLT1 DAGLA GDF15 PLCD4 MAPK14 EGF GREB1 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 5.39e-05 | 1117 | 214 | 25 | CID005280961 |
| Drug | tyrphostin B46 | 5.84e-05 | 23 | 214 | 4 | CID000002058 | |
| Drug | BAPTA | TRPC5 TRPM2 EIF6 RYR1 AGTR2 MAPK14 DNAAF10 MAPK1 IKBKB MAPK11 MAPK13 MAP2K5 | 6.11e-05 | 324 | 214 | 12 | CID000104751 |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 6.39e-05 | 184 | 214 | 9 | 5356_UP | |
| Drug | AC1L1JGQ | 6.48e-05 | 73 | 214 | 6 | CID000005034 | |
| Drug | AC1L4KA6 | 6.60e-05 | 9 | 214 | 3 | CID000158620 | |
| Drug | SC68376 | 6.60e-05 | 9 | 214 | 3 | CID000005174 | |
| Drug | FLA 365 | 6.60e-05 | 9 | 214 | 3 | CID000072776 | |
| Drug | valinomycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 6.67e-05 | 185 | 214 | 9 | 5906_UP | |
| Drug | AC1L1JYL | SPTA1 TRPC5 GPR162 DIABLO GDF15 PLCD4 PPM1A TGFBR2 MAPK14 EGF MAPK1 MAPK11 MAPK13 MAP2K5 | 6.71e-05 | 434 | 214 | 14 | CID000005262 |
| Drug | dioxane | EPOR ABCC4 BCR MMP24 MLLT1 PNPLA2 MAPK14 EGF DNAAF10 MAPK11 MAPK13 | 6.90e-05 | 278 | 214 | 11 | CID000031275 |
| Drug | AC1L1KS5 | TRPC5 RYR1 AGTR2 DAGLA PLCD4 MAPK14 EGF P2RX4 MAPK1 MAPK11 MAPK13 MAP2K5 | 8.17e-05 | 334 | 214 | 12 | CID000005631 |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; MCF7; HT_HG-U133A | TSPAN9 MAP3K1 HTR1F ADAMTS13 RASGRP1 MAPK14 EGR3 THNSL2 IKBKB | 8.18e-05 | 190 | 214 | 9 | 3966_DN |
| Drug | DENSPM | 8.63e-05 | 48 | 214 | 5 | CID000004282 | |
| Drug | 4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE | 8.79e-05 | 2 | 214 | 2 | DB08521 | |
| Drug | SB220025 | 8.79e-05 | 2 | 214 | 2 | DB04338 | |
| Drug | Pizotifen malate [5189-11-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 8.87e-05 | 192 | 214 | 9 | 6513_UP | |
| Drug | Pesticides | 8.97e-05 | 150 | 214 | 8 | ctd:D010575 | |
| Drug | Endosulfan | CFH DOK5 NR2C1 PFKP MYO3A MLLT1 UBR2 CDC42BPA GDF15 CORO1A MAPK14 GREB1 MAPK1 G6PD | 9.17e-05 | 447 | 214 | 14 | ctd:D004726 |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; HL60; HT_HG-U133A | 9.23e-05 | 193 | 214 | 9 | 2366_DN | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Down 200; 7.2uM; PC3; HT_HG-U133A | 9.23e-05 | 193 | 214 | 9 | 4067_DN | |
| Drug | Alprostadil [745-65-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A | THSD1 TSPAN9 ZBED4 ICA1 ADAMTS13 MAPK14 SNCAIP MAPK11 VPS13B | 9.23e-05 | 193 | 214 | 9 | 4179_DN |
| Drug | polyribosylribitol phosphate | 9.24e-05 | 112 | 214 | 7 | CID000002219 | |
| Drug | BPIQ-I | 9.36e-05 | 10 | 214 | 3 | CID000002427 | |
| Drug | AC1NOLIT | 9.36e-05 | 10 | 214 | 3 | CID005090286 | |
| Drug | methylseleninic acid | 9.40e-05 | 78 | 214 | 6 | CID000161597 | |
| Drug | Pimethixene maleate [13187-06-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 9.60e-05 | 194 | 214 | 9 | 7468_DN | |
| Drug | Ronidazole [7681-76-7]; Down 200; 20uM; PC3; HT_HG-U133A | 9.60e-05 | 194 | 214 | 9 | 7131_DN | |
| Drug | Seneciphylline [480-81-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 9.60e-05 | 194 | 214 | 9 | 4822_DN | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 9.98e-05 | 195 | 214 | 9 | 3523_DN | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HG-U133A | 9.98e-05 | 195 | 214 | 9 | 421_UP | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 9.98e-05 | 195 | 214 | 9 | 2278_DN | |
| Drug | Thiocolchicoside [602-41-5]; Down 200; 7uM; HL60; HG-U133A | 9.98e-05 | 195 | 214 | 9 | 1726_DN | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; MCF7; HT_HG-U133A | 1.04e-04 | 196 | 214 | 9 | 4151_DN | |
| Drug | Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.04e-04 | 196 | 214 | 9 | 4416_DN | |
| Drug | Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.04e-04 | 196 | 214 | 9 | 1685_DN | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; PC3; HT_HG-U133A | 1.04e-04 | 196 | 214 | 9 | 7155_UP | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | TSPAN9 DENND5B ICA1 SNCAIP BAZ2A LOXL2 SORBS3 PCNX1 SNRNP200 | 1.08e-04 | 197 | 214 | 9 | 2892_UP |
| Drug | Gelsemine [509-15-9]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.08e-04 | 197 | 214 | 9 | 4177_DN | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A | 1.08e-04 | 197 | 214 | 9 | 5564_DN | |
| Drug | Sulfameter [651-06-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.08e-04 | 197 | 214 | 9 | 6212_DN | |
| Drug | Isoxicam [34552-84-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.08e-04 | 197 | 214 | 9 | 1698_DN | |
| Drug | hydroxybutyrate | 1.09e-04 | 115 | 214 | 7 | CID000010413 | |
| Drug | Propafenone hydrochloride [34183-22-7]; Down 200; 10.6uM; HL60; HG-U133A | 1.12e-04 | 198 | 214 | 9 | 1722_DN | |
| Drug | Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.12e-04 | 198 | 214 | 9 | 3396_UP | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 1.12e-04 | 198 | 214 | 9 | 7023_DN | |
| Disease | late onset Parkinson's disease (implicated_via_orthology) | 3.45e-07 | 3 | 208 | 3 | DOID:0060892 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of prostate | ABCC4 GALNT3 STARD10 ITGB3 MAP3K1 ACSL4 ANTXR2 DNAJC10 BRCA1 ARL6IP1 DIABLO GDF15 TGFBR2 EGF BAZ2A GREB1 | 8.66e-06 | 616 | 208 | 16 | C0376358 |
| Disease | Prostatic Neoplasms | ABCC4 GALNT3 STARD10 ITGB3 MAP3K1 ACSL4 ANTXR2 DNAJC10 BRCA1 ARL6IP1 DIABLO GDF15 TGFBR2 EGF BAZ2A GREB1 | 8.66e-06 | 616 | 208 | 16 | C0033578 |
| Disease | Neoplasm Metastasis | 2.54e-05 | 217 | 208 | 9 | C0027627 | |
| Disease | Cardiomyopathies | 3.97e-05 | 130 | 208 | 7 | C0878544 | |
| Disease | non-syndromic X-linked intellectual disability 63 (implicated_via_orthology) | 4.95e-05 | 2 | 208 | 2 | DOID:0112050 (implicated_via_orthology) | |
| Disease | multiple mitochondrial dysfunctions syndrome 6 (implicated_via_orthology) | 4.95e-05 | 2 | 208 | 2 | DOID:0070332 (implicated_via_orthology) | |
| Disease | Cardiomyopathies, Primary | 1.29e-04 | 69 | 208 | 5 | C0033141 | |
| Disease | Myocardial Diseases, Secondary | 1.29e-04 | 69 | 208 | 5 | C0036529 | |
| Disease | WAP four-disulfide core domain protein 5 measurement | 1.48e-04 | 3 | 208 | 2 | EFO_0803264 | |
| Disease | vesicle-associated membrane protein 8 measurement | 1.48e-04 | 3 | 208 | 2 | EFO_0803254 | |
| Disease | Chromosome 22q11.2 Deletion Syndrome, Distal | 1.48e-04 | 3 | 208 | 2 | C2678480 | |
| Disease | atypical hemolytic-uremic syndrome (is_marker_for) | 1.48e-04 | 3 | 208 | 2 | DOID:0080301 (is_marker_for) | |
| Disease | B-cell lymphoma 6 protein measurement | 1.48e-04 | 3 | 208 | 2 | EFO_0021933 | |
| Disease | interleukin-17F measurement | 1.48e-04 | 3 | 208 | 2 | EFO_0021963 | |
| Disease | neurogenic locus notch homolog protein 2 measurement | 1.48e-04 | 3 | 208 | 2 | EFO_0020599 | |
| Disease | glucose-6-phosphate isomerase measurement | 1.48e-04 | 3 | 208 | 2 | EFO_0020407 | |
| Disease | Bipolar Disorder | DOK5 ABCA13 TRPM2 BCR STARD9 DNAH8 HTR4 SYNE1 RASGRP1 EGR3 MAPK1 G6PD | 1.59e-04 | 477 | 208 | 12 | C0005586 |
| Disease | Astrocytosis | 2.18e-04 | 17 | 208 | 3 | C3887640 | |
| Disease | Gliosis | 2.18e-04 | 17 | 208 | 3 | C0017639 | |
| Disease | Age-related macular degeneration | 2.61e-04 | 18 | 208 | 3 | cv:C0242383 | |
| Disease | cullin-9 measurement | 2.94e-04 | 4 | 208 | 2 | EFO_0802437 | |
| Disease | alanine aminotransferase 1 measurement | 2.94e-04 | 4 | 208 | 2 | EFO_0802260 | |
| Disease | mitogen-activated protein kinase 12 measurement | 2.94e-04 | 4 | 208 | 2 | EFO_0020576 | |
| Disease | cystatin-8 measurement | 4.88e-04 | 5 | 208 | 2 | EFO_0801509 | |
| Disease | tight junction protein ZO-1 measurement | 4.88e-04 | 5 | 208 | 2 | EFO_0803155 | |
| Disease | hephaestin-like protein 1 measurement | 4.88e-04 | 5 | 208 | 2 | EFO_0802597 | |
| Disease | interferon alpha-5 measurement | 4.88e-04 | 5 | 208 | 2 | EFO_0802642 | |
| Disease | ATP-dependent RNA helicase A measurement | 4.88e-04 | 5 | 208 | 2 | EFO_0802294 | |
| Disease | response to platinum based chemotherapy, cytotoxicity measurement | 4.88e-04 | 5 | 208 | 2 | EFO_0004647, EFO_0006952 | |
| Disease | thrombospondin type-1 domain-containing protein 1 measurement | 4.88e-04 | 5 | 208 | 2 | EFO_0802131 | |
| Disease | Colorectal Carcinoma | ABCC4 ERCC6 ABCA13 OBSCN EML2 ACSL4 DNAH8 NRCAM POLD1 SYNE1 ARFGEF1 AKAP3 TGFBR2 SNRNP200 | 4.94e-04 | 702 | 208 | 14 | C0009402 |
| Disease | Immunologic Deficiency Syndromes | 5.51e-04 | 23 | 208 | 3 | C0021051 | |
| Disease | malaria (is_implicated_in) | 6.26e-04 | 24 | 208 | 3 | DOID:12365 (is_implicated_in) | |
| Disease | pulmonary embolism | 7.08e-04 | 25 | 208 | 3 | EFO_0003827 | |
| Disease | colipase measurement | 7.28e-04 | 6 | 208 | 2 | EFO_0801485 | |
| Disease | Sjogren-Larsson syndrome (implicated_via_orthology) | 7.28e-04 | 6 | 208 | 2 | DOID:14501 (implicated_via_orthology) | |
| Disease | somatostatin-28 measurement | 7.28e-04 | 6 | 208 | 2 | EFO_0020745 | |
| Disease | Psychomotor Disorders | 1.01e-03 | 7 | 208 | 2 | C0033922 | |
| Disease | baculoviral IAP repeat-containing protein 5 measurement | 1.01e-03 | 7 | 208 | 2 | EFO_0020174 | |
| Disease | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 measurement | 1.01e-03 | 7 | 208 | 2 | EFO_0020108 | |
| Disease | X-12244--N-acetylcarnosine measurement | 1.01e-03 | 7 | 208 | 2 | EFO_0021299 | |
| Disease | Developmental Psychomotor Disorders | 1.01e-03 | 7 | 208 | 2 | C0751456 | |
| Disease | C-C motif chemokine 1 measurement | 1.01e-03 | 7 | 208 | 2 | EFO_0008041 | |
| Disease | blood N-acetylcarnosine measurement | 1.01e-03 | 7 | 208 | 2 | EFO_0022217 | |
| Disease | Myeloid Leukemia, Chronic | 1.10e-03 | 29 | 208 | 3 | C0023473 | |
| Disease | interleukin-6 measurement | 1.21e-03 | 112 | 208 | 5 | EFO_0004810 | |
| Disease | Age related macular degeneration | 1.22e-03 | 30 | 208 | 3 | C0242383 | |
| Disease | myocardial infarction (implicated_via_orthology) | 1.23e-03 | 66 | 208 | 4 | DOID:5844 (implicated_via_orthology) | |
| Disease | N-acetylcarnosine measurement | 1.35e-03 | 8 | 208 | 2 | EFO_0022101 | |
| Disease | renin measurement | 1.35e-03 | 8 | 208 | 2 | EFO_0010616 | |
| Disease | stabilin-2 measurement | 1.35e-03 | 8 | 208 | 2 | EFO_0020752 | |
| Disease | neurexophilin-1 measurement | 1.35e-03 | 8 | 208 | 2 | EFO_0008244 | |
| Disease | hair colour measurement | INSIG1 ITGB3 MAP3K1 RNF32-DT FRAS1 CDC42BPA DLGAP4 PPM1A EPG5 CTNNBL1 PCNX1 THNSL2 | 1.49e-03 | 615 | 208 | 12 | EFO_0007822 |
| Disease | Malignant neoplasm of breast | EPOR XIRP1 ERCC6 OBSCN EIF6 MAP3K1 BRCA1 MAGED2 NRCAM ZSWIM5 SYNE1 EPG5 EGF LOXL2 MACF1 IKBKB VPS13B | 1.67e-03 | 1074 | 208 | 17 | C0006142 |
| Disease | stomach cancer (is_implicated_in) | 1.70e-03 | 72 | 208 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | Acute Confusional Migraine | 1.72e-03 | 9 | 208 | 2 | C0521664 | |
| Disease | Status Migrainosus | 1.72e-03 | 9 | 208 | 2 | C0338489 | |
| Disease | Congenital adrenal hyperplasia | 1.72e-03 | 9 | 208 | 2 | C0001627 | |
| Disease | Abdominal Migraine | 1.72e-03 | 9 | 208 | 2 | C0270858 | |
| Disease | Sick Headaches | 1.72e-03 | 9 | 208 | 2 | C0700438 | |
| Disease | rectum cancer (is_implicated_in) | 1.72e-03 | 9 | 208 | 2 | DOID:1993 (is_implicated_in) | |
| Disease | Cervical Migraine Syndrome | 1.72e-03 | 9 | 208 | 2 | C0007852 | |
| Disease | chronic central serous retinopathy | 1.72e-03 | 9 | 208 | 2 | EFO_0009363 | |
| Disease | complement factor B measurement | 1.72e-03 | 9 | 208 | 2 | EFO_0008096 | |
| Disease | synaptotagmin-11 measurement | 1.72e-03 | 9 | 208 | 2 | EFO_0802108 | |
| Disease | Motor retardation | 1.72e-03 | 9 | 208 | 2 | C0424230 | |
| Disease | non-syndromic X-linked intellectual disability (implicated_via_orthology) | 1.72e-03 | 9 | 208 | 2 | DOID:0050776 (implicated_via_orthology) | |
| Disease | Hemicrania migraine | 1.72e-03 | 9 | 208 | 2 | C0018984 | |
| Disease | colon cancer (is_implicated_in) | 2.08e-03 | 36 | 208 | 3 | DOID:219 (is_implicated_in) | |
| Disease | DNA repair protein rad51 homolog 1 measurement | 2.14e-03 | 10 | 208 | 2 | EFO_0020330 | |
| Disease | membranoproliferative glomerulonephritis (implicated_via_orthology) | 2.14e-03 | 10 | 208 | 2 | DOID:2920 (implicated_via_orthology) | |
| Disease | Kunitz-type protease inhibitor 2 measurement | 2.14e-03 | 10 | 208 | 2 | EFO_0008200 | |
| Disease | stromal interaction molecule 1 measurement | 2.14e-03 | 10 | 208 | 2 | EFO_0802093 | |
| Disease | pneumonia (implicated_via_orthology) | 2.14e-03 | 10 | 208 | 2 | DOID:552 (implicated_via_orthology) | |
| Disease | glycerol-3-phosphate dehydrogenase 1-like protein measurement | 2.61e-03 | 11 | 208 | 2 | EFO_0801640 | |
| Disease | FEV/FEC ratio | DCAF8 STARD10 MAP3K1 SGMS1 LSM4 TRPM8 DENND5A DNAH5 RNF32-DT FRAS1 HTR4 DSP ACVR1C SLCO5A1 CORO1A DNAH12 ZKSCAN1 EGR3 | 2.81e-03 | 1228 | 208 | 18 | EFO_0004713 |
| Disease | lymphocyte percentage of leukocytes | SPTA1 ANTXR2 STAG3L1 LSM4 STAG3L2 STAG3L3 APBB1IP UBR2 HTR4 ADAMTS13 LRRK1 UBE2O | 2.83e-03 | 665 | 208 | 12 | EFO_0007993 |
| Disease | cancer (implicated_via_orthology) | 3.03e-03 | 268 | 208 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.11e-03 | 139 | 208 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Mouth Diseases | 3.12e-03 | 12 | 208 | 2 | C0026636 | |
| Disease | Congenital muscular dystrophy | 3.12e-03 | 12 | 208 | 2 | cv:C0699743 | |
| Disease | Calcinosis | 3.24e-03 | 42 | 208 | 3 | C0006663 | |
| Disease | Microcalcification | 3.24e-03 | 42 | 208 | 3 | C0521174 | |
| Disease | Tumoral calcinosis | 3.24e-03 | 42 | 208 | 3 | C0263628 | |
| Disease | spleen volume | 3.46e-03 | 43 | 208 | 3 | EFO_0600047 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 3.66e-03 | 13 | 208 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 3.66e-03 | 13 | 208 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 3.66e-03 | 13 | 208 | 2 | C0410203 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 3.66e-03 | 13 | 208 | 2 | C3501611 | |
| Disease | tyrosine-protein phosphatase non-receptor type 1 measurement | 3.66e-03 | 13 | 208 | 2 | EFO_0020834 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 3.66e-03 | 13 | 208 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | Migraine Disorders | 3.66e-03 | 13 | 208 | 2 | C0149931 | |
| Disease | Myopathy, Centronuclear, 1 | 3.66e-03 | 13 | 208 | 2 | C4551952 | |
| Disease | Congenital Structural Myopathy | 3.66e-03 | 13 | 208 | 2 | C0752282 | |
| Disease | adipose tissue measurement | 3.94e-03 | 45 | 208 | 3 | EFO_0004764 | |
| Disease | Gastric Adenocarcinoma | 3.94e-03 | 45 | 208 | 3 | C0278701 | |
| Disease | Tubular Aggregate Myopathy | 4.26e-03 | 14 | 208 | 2 | C0410207 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 4.26e-03 | 14 | 208 | 2 | C1834558 | |
| Disease | urinary nitrogen measurement | 4.26e-03 | 14 | 208 | 2 | EFO_0005190 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NTIAIFCETRAEWMI | 151 | O60488 | |
| WVDICNNPAMEAEIL | 636 | O60488 | |
| MLPRQWSVCEQIGVT | 386 | Q6ZRH7 | |
| WQFKEEQMSVQGICA | 326 | Q9HCE0 | |
| DAMVLWEACQQKTGE | 176 | Q9UJ72 | |
| EMCTEGAQQGLLQWL | 231 | Q8WYA6 | |
| DRTDWAIGVCRENVM | 366 | Q13410 | |
| MGQVVCDIWLSVDIT | 91 | P30939 | |
| QDRDWQRTVIAMNGI | 1011 | P11274 | |
| MWDLSCETVREQLTN | 326 | Q9Y2D8 | |
| WLGQIMCTFVTLQRD | 416 | A1IGU5 | |
| LTQRCWEVIDAQAEM | 256 | Q96KE9 | |
| QRVIMSDLQIRGWTC | 1526 | Q9UIF9 | |
| WMVIQTLTRICADAQ | 546 | Q9Y6D6 | |
| CNGISQWVQLMVLSR | 251 | O95267 | |
| CDDTRTLNQWVMGIR | 401 | Q7Z5R6 | |
| CWASVMLTNGKEQVI | 46 | Q8NER5 | |
| SIAAMLTVWACQGRQ | 126 | Q8NER5 | |
| NQWQSCEALRVMGRI | 446 | Q8NER5 | |
| LAWMGVINSCEVIAV | 281 | P50052 | |
| VSLMRPQEGDEVCIW | 466 | P58335 | |
| CAMNNWLRSAEIGQE | 716 | Q8IYW2 | |
| IASGSEDCTVMVWQI | 96 | Q9ULV4 | |
| WQTIMKEVREGCAAV | 4896 | Q86UQ4 | |
| MIVSLAAVAWVGQQV | 141 | Q15041 | |
| VLLSAGCDNVIMVWD | 146 | P31146 | |
| NVIMVCRKGEWVALN | 61 | P08603 | |
| EVWQVIIGARAEMTS | 131 | Q9NR28 | |
| ANGWGMNIAEVVCRQ | 716 | Q9NR16 | |
| LQAETERLEGWCCQM | 811 | Q9Y2H0 | |
| VQETAWEELIRTGQM | 231 | Q03468 | |
| MDSQQVWDRCQVCGG | 536 | Q76LX8 | |
| CAQGVIWTVFNQTVM | 336 | Q16790 | |
| RDTTCMIWQITQQGG | 2461 | Q6ZS30 | |
| VGLAVCVWMQARVSP | 191 | Q8NI28 | |
| LMNTIVFEDCRNQWS | 986 | Q9H2T7 | |
| NELFTLGLAQCWQVM | 431 | P13056 | |
| LGLAQCWQVMNVATI | 436 | P13056 | |
| GIMGIQVNWDCNLDR | 251 | Q99571 | |
| RQVTTEEAQTWCMEN | 131 | Q9NP90 | |
| SVNVVRAMIDNWDVL | 411 | Q6ZRI8 | |
| ITGADQNRELKMWCT | 371 | Q6P2E9 | |
| ESCMSQIGWNRIIVE | 156 | P11413 | |
| RQVIAEECVAFMLNW | 656 | Q75QN2 | |
| MQVAVCGSLIGWRNV | 256 | P05556 | |
| DRVGNITVIGWQMEE | 161 | Q96PE3 | |
| WQEEVAAVVVVGSCM | 11 | Q9H477 | |
| VQETAWEELIRTGQM | 231 | P0DP91 | |
| ICLMVANTLIGNWDR | 311 | O75439 | |
| NILRDWMGCNQKEVE | 561 | Q9Y5R2 | |
| IWSVGCILAEMLSNR | 211 | P28482 | |
| CTDNGIMIAWNGIER | 356 | Q9H4B0 | |
| EDIRWMKEQTGSICQ | 361 | Q96AD5 | |
| NQTVDIWSVGCIMAE | 201 | Q15759 | |
| SENWGLTEAMVACRQ | 451 | Q96JB6 | |
| NDRGLQLVANSMVWV | 1326 | Q86XX4 | |
| MNGNRSSEAVIWEVL | 381 | Q9UNF1 | |
| LSEQLERMSIQCDVW | 201 | Q9H2G9 | |
| IVISDDSCVMWNVVD | 1641 | Q4ZG55 | |
| LLAWREMEQAVELCG | 511 | O14920 | |
| QVDIATQGWFIGLMC | 1161 | Q92823 | |
| RADVRTVWEQCVAIM | 331 | Q16538 | |
| WQMVTGCGSIQERAV | 556 | Q8NCE2 | |
| IPEGCIQRWAAEMVV | 901 | Q96S38 | |
| GMKVSCQLQVQRSLW | 1581 | Q38SD2 | |
| NQTVDIWSVGCIMAE | 201 | Q16539 | |
| ECLVADNSVTVAWRM | 206 | Q9BXM9 | |
| WQECNLNLMREEGIK | 81 | Q9Y234 | |
| NINLKMGVEWTSCAE | 626 | P06681 | |
| QWVRMENVTVLGEDV | 316 | Q9Y5P6 | |
| EAMECSDVIWQRGLL | 346 | Q9NS86 | |
| QNWGIVEAMVVCRQL | 466 | Q9Y4K0 | |
| MEPVQGENKRDCWTV | 156 | Q96MX6 | |
| SGERVILQCWSDIMF | 136 | P43629 | |
| EWLANETMQEGLRLC | 1716 | Q96RV3 | |
| NAAVVSMWVCRALEE | 426 | Q13163 | |
| LMNQRVCLQITGSSW | 136 | Q8NHB1 | |
| LMNQRVCLQITGSSW | 136 | Q96R30 | |
| QTVQRMLVAASWACA | 141 | P47881 | |
| TIMNWQVCTVLVGIA | 126 | Q8NGF9 | |
| EGWEEQMCVKLSENR | 246 | Q01813 | |
| CVVGIQALAEMDRWQ | 86 | Q7Z412 | |
| LWEKSSCQIIQFMEG | 461 | Q5TAQ9 | |
| CEMIVNLVSVGRVLW | 2626 | Q96JB1 | |
| WASVMRCIAVFVGIN | 161 | O15503 | |
| REWPGQVVLCISQMF | 1101 | Q6ZR08 | |
| CNVVWLDEMTATRAL | 161 | Q53F19 | |
| CVDLMVWAVKDEQGA | 441 | P42356 | |
| SRLEAMNQCWESVLQ | 2431 | O94854 | |
| NQTVDIWSVGCIMAE | 201 | O15264 | |
| IQAQQCLEGMWSVSR | 221 | Q9ULI4 | |
| DEWCKVLQMECVGTR | 101 | Q9P104 | |
| IGQALWAVEQLQMEA | 11 | A0A1W2PPG7 | |
| LQQCLLADVSGIDWM | 2466 | Q92616 | |
| ADWVLSPREVQVTMC | 226 | Q99988 | |
| MNVVVVDWNRGATTL | 101 | Q8WWY8 | |
| QGCLQNTVNDFWRMV | 331 | Q06124 | |
| ELWVQVCGASAGMLQ | 436 | Q8IZL8 | |
| VLQGQWMRLCTSATE | 371 | P31930 | |
| QDCGTDVLDLWTLMQ | 171 | Q2TAA2 | |
| WRGCIPTMARAVVVN | 181 | Q02978 | |
| CTLNWDVGFVIQTMN | 1276 | O75694 | |
| EPWVICSVSEDNIMQ | 386 | Q09028 | |
| EVIAAGMVVNDWCAF | 191 | P56537 | |
| TLSCEVAQAQTEVMW | 1001 | Q5VST9 | |
| TLSCEVAQAQTEVMW | 1461 | Q5VST9 | |
| GMFQWCVRQSAEVEN | 991 | O15439 | |
| MQVAACPEEIGWRNV | 241 | P05107 | |
| QMCEAPVVTREWVLD | 1826 | P38398 | |
| QAVVDNVCWQMSLDR | 91 | Q9UHY7 | |
| QVWCQFGEDRLNDRM | 1076 | Q9P2N4 | |
| CDMANWIIIDRQAED | 221 | Q6ZMU1 | |
| GQVEVWLNRVLDRMC | 1651 | Q9UFH2 | |
| VCNIEKNVSGMAINW | 111 | P01133 | |
| WEIQEDSRLMCSSVQ | 176 | Q9BQI4 | |
| NFIQWCRKEMGIQEV | 116 | Q8NHY3 | |
| NIEMSFRVWQCGGQL | 391 | Q14435 | |
| MSFRVWQCGGQLEII | 386 | Q8NCL4 | |
| NWCQDNIISLMSAGI | 96 | Q06889 | |
| VRDAEAQIQAWTNMV | 2106 | Q5TH69 | |
| HVTSECLGWMRQQRA | 186 | P15924 | |
| IQATSREIMWINDCE | 276 | P15924 | |
| WTREADRVILTMCQE | 2156 | Q3T8J9 | |
| WLVDCVMVRNEITGH | 1006 | Q6ZUT9 | |
| GNLLVMVAVCWDRQL | 36 | Q13639 | |
| WICISGELGETQIMQ | 976 | Q6IQ26 | |
| AWQDDMQVVIGQQLR | 451 | A1A5D9 | |
| WVTMLGQCLCSVAQV | 201 | Q9Y5Y0 | |
| DARQDSLVQWEMEVC | 746 | Q9P0L2 | |
| SCDNWMNINLREVIC | 31 | Q9Y4Z0 | |
| AKNVTLGMVVCNWVV | 131 | Q9Y4D2 | |
| AIMQATVCDEKIGWR | 251 | P05106 | |
| VRWENRTMNCIVNVF | 96 | P51808 | |
| LEVLSERCWGTMQAV | 331 | P19235 | |
| ARVRNWLGNEIEVMV | 741 | Q2VIQ3 | |
| EAVEALVCMSSWGQR | 46 | O14901 | |
| GLIWTSEFILACQQM | 386 | Q8N4M1 | |
| AVRNMEWATATCVLG | 546 | O95834 | |
| DWMVFVRGPEQCDIQ | 31 | Q03111 | |
| LVNVGWMDCATQDNL | 286 | Q8IXB1 | |
| PVAEGMNEIWLRCDN | 446 | Q96AC1 | |
| VEVENVMVWTVGVCR | 386 | Q8WVV5 | |
| ERLGWAVQCQEPLTM | 1621 | P21817 | |
| EIRFMVDTDIVGCNW | 251 | P28340 | |
| VEAFLMQASGVRWCV | 211 | Q7Z7J5 | |
| EWGDQVTNEIVRQLM | 2666 | Q8TE73 | |
| IAWARTELLNVCMNA | 26 | P15328 | |
| MNTQLCVGLVVAAWV | 136 | Q15615 | |
| LNDLEACVMQEVWVG | 116 | P05013 | |
| DTWLTVNRMEQCRTE | 151 | Q05084 | |
| FCAELMIQNWTLGAV | 201 | O43427 | |
| MELVGCLFSRNWNVR | 566 | Q13233 | |
| GWLNCQRLVIDEISM | 296 | Q9H611 | |
| ICNLAVITMDERVWT | 141 | P59542 | |
| ICNLAVITMDERVWT | 141 | P0DSN6 | |
| DVECRSQWSTMELLQ | 236 | Q9BYJ4 | |
| AQIWRVAEQLEVGMV | 476 | P51649 | |
| GVSVWVQAVEMDRTL | 51 | Q9Y365 | |
| ANSVEEAQIWMRGLQ | 106 | Q9BRC7 | |
| QMNGRWDRVCSLLEE | 8526 | Q8NF91 | |
| QQVCMAVDIGRHRWD | 556 | Q3BBV2 | |
| QQVCMAVDIGRHRWD | 591 | P0DPF3 | |
| QQVCMAVDIGRHRWD | 591 | Q6P3W6 | |
| QQVCMAVDIGRHRWD | 591 | Q86T75 | |
| EQQVCMAVDIGRHRW | 861 | Q5TAG4 | |
| QQVCMAVDIGRHRWD | 251 | Q5TI25 | |
| QVCMAVDIGRHRWDQ | 321 | Q8N660 | |
| QVCMAVDIGRHRWDQ | 321 | A0A087WUL8 | |
| QQVCMAVDIGRHRWD | 251 | B4DH59 | |
| TVQVGNCLQVMWLAD | 141 | Q9NVX7 | |
| SGERVILQCWSDIMF | 136 | Q14943 | |
| DDMVDVIWRQLISSC | 1701 | Q96Q15 | |
| TWMEELICNTTVERC | 2666 | Q96Q15 | |
| GAVIDTTCMLWQQEC | 706 | Q9H2Y9 | |
| ALVLWEMTSRCNAVG | 451 | P37173 | |
| GQLECVRWMVSETEA | 396 | Q9Y6H5 | |
| DEAITQTMGRCWDEN | 371 | Q86YJ6 | |
| VCWRLVEQVPDRAME | 251 | Q9Y4R8 | |
| FLDMIRETEQCWVQP | 31 | Q8NEX5 | |
| IRAICIEEIGCWMQS | 21 | P0CL83 | |
| LGVQVRPENWCSQMD | 3441 | Q9P2P6 | |
| LANHVVDRVWQECNM | 371 | Q9UHV7 | |
| NVQWMAIFSEQLCVG | 1361 | Q5VT25 | |
| MAWEEIAQCVNAVGE | 46 | Q8NCY6 | |
| VNGAEVEVQSWLRMS | 696 | Q8WXE9 | |
| MSEKVDWLQSQNGVC | 1 | O75969 | |
| NIAIFCETRAEWMIA | 161 | O95573 | |
| VRQIQEEMTQDGTWR | 66 | Q9BXL8 | |
| QEAWIQAMGEAARVQ | 146 | Q9Y2H5 | |
| LTLWRQQGTNMTDKC | 396 | Q9P217 | |
| IWVNCQVSMEPEDNR | 361 | P0CB48 | |
| RGVAQCLRDLVAMQW | 421 | Q86XI8 | |
| DQFIILACDGIWDVM | 231 | P35813 | |
| IWDVMGNEELCDFVR | 241 | P35813 | |
| GMLKVACAEEWQESR | 81 | O75663 | |
| QLSVDNGLWRVTLCM | 746 | O94759 | |
| NGLIIVWNVETKDCM | 251 | O75717 | |
| EECMLIQRNTETWGL | 331 | Q9NS62 | |
| VRGCTNAVIIWFMDN | 216 | O95858 | |
| DVMWQDGSVECNIRS | 556 | Q9C0C9 | |
| VWNVTNGQCMEKATL | 91 | Q3MJ13 | |
| VAQVVAEMWRRNGLS | 656 | Q8IWV7 | |
| QWAFSICEINGMILV | 181 | Q86VZ5 | |
| IRAICIEEIGCWMQS | 21 | P0CL84 | |
| VMQQCDDGWFVGVSR | 641 | O60504 | |
| LTQPLCEWMIQVARD | 31 | Q8IWL8 | |
| QGNCDQVESWMVARE | 1401 | P02549 | |
| QTMAEWLGCEAIVRQ | 656 | Q2NKQ1 | |
| CVLERRIVPWMQQES | 66 | H0YL09 | |
| AAQNIVEDMEQRGIW | 231 | Q16222 | |
| AWLREMNCPETIAQI | 146 | Q6UW63 | |
| MIEVNNVTKARDCWA | 191 | P37288 | |
| MEEVIQAGLAQWSRQ | 1 | Q6Q795 | |
| VASGLQMWQVVDQCS | 121 | Q96C00 | |
| IQVVVASRSLCWGMN | 1641 | O75643 | |
| TIRNLDCIRMIWEEQ | 36 | Q8TA94 | |
| DCIRMIWEEQNTEDQ | 41 | Q8TA94 | |
| QKISAQENMWRAVSC | 2116 | Q7Z7G8 | |
| IRAICIEEIGCWMQS | 21 | P0CL85 | |
| FQWVQGDVCEVQLMV | 591 | Q96Q05 | |
| TISDGIVQQHCMWQD | 866 | Q9UL62 | |
| DMAVSLILEEWGCQN | 231 | P17029 | |
| IQTCWLQLAEFREMG | 191 | Q9H1J5 | |
| AWGMVSNRDTLIRNC | 216 | Q7Z2W7 | |
| LCGMQEVDLADWQRN | 801 | Q9H0M0 | |
| IMNSLIESWCRNSEV | 1566 | Q8IWV8 | |
| PTEGDVQCMRWIFEN | 86 | Q702N8 | |
| NAWNIIQAEMRCCGV | 136 | O75954 | |
| MESRSVAQAGVQWCD | 1 | Q8N7M2 | |
| QQGAGMTDKCRQLWD | 321 | Q9H7M6 | |
| LISCDQWEVMQSVCR | 921 | O75132 | |
| WMAPEVIACEQQLDT | 191 | Q8NEV4 |